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Diet-induced obesity is a serious public health and economic problem. Obese people are at higher risk of developing type 2 diabetes (T2D), cardiovascular diseases and cancer, all lead-
ing causes of death worldwide (https://www.who.int). Today, bar-
iatric surgery is the most effective treatment to achieve long-term 
weight loss and notably leads to diabetes remission1. Surgical pro-
cedures cause profound changes in secretion of gut hormones with 
beneficial effects on whole body metabolism, appetite and food 
intake2. These findings suggest gut hormones as candidates for new 
therapies against obesity and diabetes3.
The gut, as the body’s digestive and largest endocrine system, 
serves as a central regulator of energy and glucose homeostasis and 
quickly responds to dietary and nutritional changes4–8. Constant 
overnutrition is thought to lead to intestinal maladaptation and dys-
function and to contribute to the development of obesity and pre-
diabetes8. This is evident as two hallmarks of obesity, excessive food 
intake and a reduced stimulation of postprandial insulin secretion 
by gut hormones, are linked to impaired gut function9. Moreover, 
differences in gut morphology and physiology have been observed 
between lean and obese individuals8,10,11. Tackling gut dysfunction at 
an early stage of disease might therefore be a promising treatment 
option to fight obesity and the resulting risks and complications.
Intestinal functions are carried out by specialized epithelial cells lin-
ing the gut: absorptive enterocytes, antimicrobial-peptide-secreting 
Paneth cells, hormone-secreting enteroendocrine cells (EECs), 
mucus-secreting goblet and chemosensory tuft cells. The cells 
of the intestinal epithelium are constantly generated from ISCs12. 
ISC identity is defined by multi-lineage potential and self-renewal 
capacity, but also by properties that are not hard-wired, such as the 
proliferative, epigenetic and metabolic state12,13. High cell turnover 
and cellular plasticity contribute to the natural adaptive capacity of 
the gut, but the mechanisms underlying maladaptation in response 
to an obesogenic diet are still unclear. Specifically, we do not know 
whether the hormonal imbalance and increased absorptive capac-
ity emerge at the level of early lineage commitment from ISCs9,14. 
Moreover, the functions of enterocytes and EECs differ between gut 
regions15–17. Proximal enterocytes, for instance, are specialized to 
absorb iron and nutrients (carbohydrates, fat and protein), whereas 
distal enterocytes absorb bile acids and vitamin B12. Proximal EEC 
types secrete serotonin and ghrelin, whereas distally located EECs 
preferentially secrete Glp-1 (ref. 17). Gut functions are also spa-
tially compartmentalized along the crypt–villus axis. Enterocytes 
shift their expression profile from an antimicrobial to a nutri-
ent absorption to an immunomodulatory program while migrat-
ing from the bottom of the villus to its tip. The spatial–functional 
compartmentalization of nutrient absorption is achieved through 
zoned expression of nutrient transporters, with the highest expres-
sion of carbohydrate and amino acid transporters in the mid-villus 
region and of apolipoproteins and fatty acid transporters, such as 
Apoa4 and Fabp1, at the villus tip18. Similarly, enteroendocrine cell 
types switch their hormone expression pattern along the crypt–vil-
lus axis19. Regional identities are thought to be determined at the 
level of the ISCs by epigenetic mechanisms, and the crypt–villus 
compartmentalization is at least partly established by growth-factor 
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gradients, but it is unknown whether and how the compartmental-
ization of gut functions is affected by an obesogenic diet20,21.
Developing pharmacological approaches to counteract obesity 
and diabetes require in-depth understanding of the mechanisms 
that underlie maladaptation and endocrine dysfunction in the gut, 
specifically during the transition from a healthy to an obese and to 
a prediabetic state. In this study we combined single-cell profiling 
with genetic lineage labelling and tracing of ISC fate decisions and 
in situ metabolomics to elucidate the cellular and molecular mech-
anisms that underlie intestinal maladaptation to an obesogenic 
western-style high-fat/high-sugar diet (HFHSD) in mice.
results
HFHSD remodels the intestinal mucosa and leads to obesity.  
To study mechanisms of intestinal maladaptation to an HFHSD, 
we maintained male Foxa2–Venus fusion (FVF) reporter mice on 
a diet regimen for 12 weeks22. Over this time, mice on an HFHSD 
gained significantly more body weight (fat and lean mass) than did 
control diet (CD)-fed mice, and this was accompanied by an increase 
in length and weight of the small intestine (SI), increased villus 
length and decreased crypt density (Extended Data Fig. 1a–l). Crypt 
depth, number of cells per crypt and cell sizes in crypts and villi 
were not changed (Extended Data Fig. 1k,m–p). Histological assess-
ment of the SI mucosa showed cellular fat inclusions in the villi of 
HFHSD-fed mice, suggesting disturbances in fatty acid metabolism 
in the gut epithelium (Extended Data Fig. 1q). Metabolic assess-
ment showed that our diet-induced obese mice developed predia-
betes, which was characterized by fasting hyperglycaemia, impaired 
glucose tolerance and pronounced hyperinsulinaemia as well as 
insulin resistance (Extended Data Fig. 1r–u). Thus, an HFHSD 
changes mucosal morphology, which is indicative of altered ISC 
homeostasis and lineage recruitment.
HFHSD alters ISC lineage allocation and regional identity. To 
dissect the metabolic impact of an HFHSD on ISC lineage recruit-
ment, we employed single-cell RNA-sequencing (scRNA-seq) 
of crypt cells from the SI of CD- and HFHSD-fed FVF reporter 
mice (Fig. 1a). FVF-lineage labelling enabled us to flow sort and 
enrich for ISCs and EECs, cell types that together usually make up 
less than 6% of the intestinal epithelial cells (Fig. 1a and Extended 
Data Fig. 2a)17. This enrichment strategy not only allowed us to 
assess compositional changes on an HFHSD, but also to molecu-
larly and functionally characterize rare crypt-cell types. We profiled 
27,687 cells obtained from three biological replicates of CD- and 
HFHSD-fed mice and detected on average 3,500 genes per cell 
(Extended Data Fig. 2b). Unsupervised graph-based clustering 
and annotation based on known marker genes revealed all mature 
intestinal cell lineages as well as ISCs and distinct progenitor states 
for each intestinal lineage (Fig. 1b,c and Extended Data Fig. 2c,d). 
Lineage marker gene expression as well as the expression of known 
regulators that drive intestinal lineage decisions toward the 
absorptive (for example Notch1) and secretory lineages (Dll1, Dll4 
and Atoh1) and PAGA topology23 were unchanged between diet 
conditions (Fig. 1c, Extended Data Fig. 2c–f and Supplementary 
Table 1). Corresponding subtypes showed high correlation in their 
transcriptomes, indicating that an HFHSD did not alter lineage 
identities (Extended Data Fig. 2g). Instead, we observed a shift of 
cell densities indicating that an HFHSD impacts the composition 
of the mucosal epithelium (Fig. 1d,e and Extended Data Fig. 2d,h). 
Note that we excluded the Paneth cell lineage from the scRNA-seq 
analysis because of reported sampling issues, which might impact 
cell-type ratios17. To assess whether the HFHSD affects regional 
subtypes, we separated cell types into proximal and distal cells 
using recently described regional signature genes (Extended Data 
Fig. 3a)17. We found that the fractions of ISCs, enterocytes and gob-
let cells with proximal identity increased in mice fed an HFHSD 
(Fig. 1f,g and Extended Data Fig. 3b). Together, these data sug-
gest that an HFHSD boosts formation of the absorptive and goblet 
cell lineage and promotes proximal cell identities, indicating that 
the intestine adapts cell-type composition and specific cellular 
functions to nutrient availability.
Altered lineage relations in the crypt translate into the villus. As 
our scRNA-seq experiment indicated alterations of lineage abun-
dances in the crypt on HFHSD, we next performed short-term 
genetic lineage tracing of ISC fate decisions using a dual-fluorescent 
inducible Cre-reporter Foxa2nEGFP-CreERT2/+;Gt(ROSA)26mTmG/+ mouse 
(Fig. 2a)24,25 to determine how these changes impact the composi-
tion of the mature villus compartment. Foxa2 is expressed in qui-
escent and rapidly dividing ISCs (Supplementary Fig. 1). In this 
mouse model, Foxa2 expression-driven CreERT2 induces a switch 
from membrane-Tomato (mT) to membrane-GFP (mG) in ISCs 
after tamoxifen administration. At 48 h after Cre-ERT2 activa-
tion by tamoxifen, we observed labelled mG-positive ISCs next 
to Paneth cells at the crypt bottom and labelled single cells and 
small cell clusters in duodenal crypts at similar frequencies in CD- 
and HFHSD-fed mice (Extended Data Fig. 4a). To determine the 
effect of an obesogenic diet on ISC lineage recruitment, we anal-
ysed the abundance of mature enterocytes, goblet cells and EECs 
in Cre-reporter labelled mG-positive lineage ribbons in the villi of 
CD- and HFHSD-fed mice 70 h after tamoxifen induction (Fig. 2b). 
In mice fed an HFHSD, longer ribbons (>6 cells) appeared more 
frequently, suggesting higher ISC or progenitor proliferation or 
increased cell turnover (Fig. 2c,d and Extended Data Fig. 4b). 
Within the lineage ribbons, total numbers of villin+ enterocytes 
and Muc2+ goblet cells were increased, whereas the number of 
ChgA+ EECs was reduced (Fig. 2c,d). The relative abundances of 
enterocytes and ChgA+ EECs within lineage ribbons were dimin-
ished owing to the large increase in goblet cell numbers in mice fed 
an HFHSD (Fig. 2c and Extended Data Fig. 4c). In accordance, 
Fig. 1 | HFHSD alters lineage allocation from ISCs and shifts the regional identity of cells. a, Experimental design for FVF-based SI crypt-cell enrichment 
by flow cytometry and scRNA-seq. Single FVF+ and whole crypt cells from SI crypts of CD- and HFHSD-fed FVF mice were isolated in equal numbers  
by flow cytometry and combined for each sample. FVF-enriched single-cell samples were then transcriptionally profiled by scRNA-seq. b, Uniform 
manifold approximation and projection (UMAP) plot of 27,687 profiled single SI crypt cells. Colours highlight clustering into major intestinal cell types 
based on the expression of previously published marker genes. One cluster of cells could not be assigned owing to a missing marker gene signature (NA).  
c, Heatmap depicting scaled expression of cell-type-specific gene signatures in CD- and HFHSD-derived cells. Cells are represented in columns and genes 
are represented in rows. Colour bars indicate cell types assigned to both cells and genes. Selected known marker genes for every lineage are indicated. 
d,e, Cell-type composition differences in CD- and HFHSD-derived single-cell samples visualized by cell density projected onto the two-dimensional 
UMAP embedding (d) and quantified as proportions over cell types (mean ± s.e.m. of biologically independent samples, n = 3 mice per group, Dirichlet 
multinomial model) (e). Densities were estimated using Gaussian kernels. * Indicates a credible shift (95% highest posterior density interval of the 
frequency shift modelled by a Dirichlet multinomial model does not overlap 0). n = 3 CD mice, n = 3 HFHSD mice. f, UMAP coloured by the regional 
identities of cells in ISCs and goblet cell and enterocyte cell lineage. Subclusters were classified on the basis of expression of regional marker genes.  
g, Proportions of cells with proximal or distal identity in ISCs and enterocyte and goblet cell lineage (mean ± s.e.m. of biologically independent samples). 
n = 3 CD mice, n = 3 HFHSD mice.
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goblet cell numbers in the duodenal villi were increased and num-
bers of ChgA+ EECs were reduced in the duodenum and ileum of 
HFHSD-fed FVF mice (Fig. 2e–j and Extended Data Fig. 4d). Note 
that the number of ileal goblet cells was not altered, suggesting that 
gut regions are differently affected by an HFHSD (Extended Data 
Fig. 4e). As we excluded Paneth cells from our scRNA-seq analysis, 
we determined the Paneth cell numbers in situ and found no differ-
ence between CD- and HFHSD-fed mice (Extended Data Fig. 4f,g). 
To understand whether the shift in regional identity in crypt cells 
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Fig. 2 | Altered lineage relations in the crypt translate into the mature villus compartment. a, Foxa2nEGFP-CreERT2/+;Gt(Rosa26)mTmG/+ lineage-tracing model. 
mT Foxa2-negative cells (red) convert into mG Foxa2-lineage-positive cells (green) upon Foxa2-promoter-driven Cre expression via an intermediate 
(mTmG+, yellow) state. pCA, chicken β-actin core promoter with a CMV enhancer. b, Experimental scheme of short-term lineage tracing of Foxa2-positive 
cells using the Foxa2nEGFP-CreERT2/+;Gt(Rosa26)mTmG/+ mouse model. c,d, Representative laser scanning microscopy (LSM) images of Cre-driven recombination 
in the duodenum of CD- and HFHSD-fed Foxa2nEGFP-CreERT2/+;Gt(Rosa26)mTmG/+ (c) and analysis of lineage-positive cells (d) 70 h after tamoxifen induction. 
Single converted mG+ cells and lineage ribbons (green) containing Muc2+ goblet cells (red), ChgA+ EECs (white) and villin+ enterocytes (white) are 
observed in crypts and villi. Scale bar, 100 µm. For Foxa2-lineage analysis, only confluent mG+ cell patches located in the villi were considered (n = 3 
mice per group). Data are mean ± s.e.m. Statistical significance was determined by two-tailed Student’s t-test. DAPI, 4,6-diamidino-2-phenylindole. 
e–j, Abundances of mature intestinal cell types are altered in HFHSD-fed FVF mice. e,g, Representative LSM images (e) of goblet cells (Muc2+) and 
quantification thereof (f,g). Scale bar, 75 µm, n = 3 mice per group. h–j, Representative LSM images (h) of ChgA+ EECs and quantification thereof (i,j). 
Scale bar, 75 µm, n = 4 mice per group. Data are mean ± s.e.m. of biologically independent samples. Statistical significance was determined by two-tailed 
Student’s t-test.
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scRNA-seq of villus cells from the SI (Extended Data Fig. 5a–c). 
We focused on enterocytes because regional and spatial compart-
mentalization of enterocyte function is well described and classified 
them into proximal and distal enterocytes using reported regional 
transcription factors (Extended Data Fig. 5d,e)17,18. Consistent 
with crypt scRNA-seq data, we also found an increased fraction of 
proximal-type villus enterocytes in mice fed an HFHSD (Extended 
Data Fig. 5f). Furthermore, proximal and distal-type enterocytes 
showed upregulation of functional proximal genes such as Fabp1 
and Apoa4 (Extended Data Fig. 5g).
Next, we assessed whether enterocyte zonation is affected by an 
HFHSD. We inferred a pseudospatial ordering of cells using previ-
ously reported zonation markers and partitioned cells into five zones 
along the axis from villus bottom to tip (Extended Data Fig. 6a)18. 
We found that in proximal and distal enterocytes, the spatial expres-
sion pattern of several genes associated with carbohydrate and fatty 
acid absorption was altered in HFHSD-fed mice (Extended Data 
Fig. 6b)18. Analysis of Fabp1 and Apoa4 immunolocalization in the 
ileum and duodenum confirmed the proximalization of enterocytes 
and altered enterocyte zonation. The expression zones of Fabp1 and 
Apoa4 were enlarged on an HFHSD and reached from villus tip to 
villus bottom (Extended Data Fig. 6c–k).
Thus, more goblet cells and proximal-type enterocytes are gen-
erated under HFHSD conditions, which leads to morphological 
changes of the gut mucosa and an increase in fatty acid transport 
and absorption. Reduced ChgA+ EEC numbers imply changes in 
specific EEC subsets.
HFHSD changes the allocation of the enteroendocrine lineage. 
Secreted gut hormones are critical regulators of food intake and sys-
temic metabolism along the gut–brain–pancreas axis and hormonal 
imbalance is linked to the metabolic syndrome26,27. To elucidate the 
mechanisms underlying EEC dysfunction in response to an obeso-
genic diet, we first refined the clustering of our 2,865 EEC lineage cells 
into distinct subpopulations, which revealed five enteroendocrine pro-
genitor (EEP) clusters characterized by expression of Sox4, Ngn3, Arx/
Isl1, Ghrl and Pax4, respectively, and six polyhormonal EEC clusters: 
SILA cells (coexpress Sct, Cck, Gcg, Ghrl and Gal), SILP cells (coex-
press Sct, Cck, Gcg and Pyy), SIK cells (coexpress Sct, Cck and Gip), 
SAKD cells (coexpress Sct, Cck, Ghrl, Gip and Sst), SIN cells (coex-
press Sct, Cck, Gcg and Nts), enterchromaffin (EC) cells (coexpress Sct, 
Tac1, Tph1) and Reg4+ EC cells (coexpress Sct, Tac1, Tph1, Ucn3 and 
Reg4) (Fig. 3a,b and Extended Data Fig. 7a,b)17,19,28. We also identi-
fied a population of heterogeneous EECs coexpressing endocrine and 
ISC markers that we termed Lgr5+ EECs and which are reminiscent 
of Lgr5+ label-retaining cells (Fig. 3a,b and Extended Data Fig. 7a)29. 
Notably, we found that Lgr5+ EECs are characterized by active Bmp 
signalling, which has been shown to regulate the hormonal plasticity 
of EECs (Extended Data Fig. 7c)19. To determine EEC lineage hierar-
chy and to understand the relationship of EEP and mature clusters, 
we used PAGA in combination with RNA velocity (Methods)30. The 
abstracted graph represents possible differentiation paths that cells 
follow and RNA velocity predicts the future state of a cell based on 
gene expression state (gene induction or repression), thus indicating 
the direction of differentiation. We observed two main differentiation 
trajectories from the Sox4+ progenitors to mature subtypes: (1) a path 
via Arx/Isl1+ and Ghrl+ progenitors to peptidergic EECs (SILA, SILP, 
SIK and SAKD) and (2) a route via Pax4+ progenitors to serotonergic 
EC and mature Reg4+ EC cells (Fig. 3c). To identify transcriptional sig-
natures and regulators of EEC lineage allocation, we extracted genes 
that were either only transiently expressed in a specific EEP stage or 
mature cell subtype (state-specific genes) or turned on with sustained 
expression in subsequent states (global or lineage-specific genes) 
(Fig. 3d, Extended Data Fig. 7a,d and Supplementary Tables 2 and 3). 
Transiently expressed markers in progenitor stages (for example Sfrp5 
in Ngn3+ progenitor) are potentially important for specification. 
Global or lineage-specific markers (for example Nefm in peptidergic 
lineage) might regulate endocrine cell identity. Together, our data 
confirm EEC lineage differentiation from an early common progeni-
tor into EC-biased (Pax4+) and non-EC-biased (Arx/Isl1+) progeni-
tors and their respective molecular programs17,28,31. We then compared 
EEC lineage allocation in CD- and HFHSD-fed animals. We found 
that an HFHSD reduces the number of Sox4+ early EEPs, increases 
the fraction of Ngn3+ EEPs, reduces the number of Lyz1−BrdU+ cells 
that correspond to label-retaining Lgr5+ EECs and affects mature 
SILA and Reg4+ EC cells, which are most abundant in the duodenum 
(Fig. 3e–o and Extended Data Fig. 7e–i)17. Serotonin (5-HT)+Reg4+ 
EC numbers were decreased in HFHSD crypts, whereas Ghrl+ 
SILA cells were more abundant in the duodenal crypts and villi 
(Fig. 3h–m). Numbers of ileal located SILA/SILP cells expressing 
Gcg, which encodes the incretin Glp-1, were also increased with an 
HFHSD (Fig. 3n,o). We next assessed whether an HFHSD induces 
transcriptome changes that might affect EEC lineage allocation or 
function. Single-cell messenger RNA expression levels of hormones 
did not differ between CD and HFHSD EEC subsets (Extended Data 
Fig. 7j). However, genes associated with metabolism (for example 
Slc5a1, Acadl in SIK cells), vesicular trafficking machinery and the 
secretome (for example Cplx2 in EC and Sct in SIK cells) as well as 
signalling (transduction) (for example ID1/ID3 in Sox4+ progeni-
tors, Gnas in EC cells) and transcription factors (for example Cdx2 
in Sox4+ progenitor, Hmgn3 in EC cells) were differentially expressed 
between CD and HFHSD conditions (Extended Data Fig. 7k–m and 
Supplementary Table 4).
Next, we examined EEC functionality by assessing hormone 
secretion (Extended Data Fig. 7n). Intestinal EC cells produce over 
90% of the body’s serotonin32. We found that basal plasma levels 
of serotonin were lower in mice fed an HFHSD, which correlates 
with reduced numbers of 5-HT+ EECs (Reg4+ EC cells) (Extended 
Data Fig. 7o). By contrast, despite a higher number of Ghrl+ SILA 
EECs, plasma levels of ghrelin were reduced in HFHSD-fed mice 
Fig. 3 | eeC lineage formation and composition in homeostasis and upon HFHSD. a, Colour-coded UMAP plot of 2,865 EEC lineage cells from CD-  
and HFHSD-derived samples. Cluster annotation was based on known marker genes and labelling of mature EEC subtypes as previously described17.  
b, Expression levels of selected EEC markers (hormones and transcription factors) across EEC clusters plotted in UMAP space. c, Streamline plot of 
RNA velocity projected into UMAP space showing the direction of cell differentiation along trajectories for the endocrine lineage in CD-derived samples. 
Arrows indicate estimated future states of cells. d, Heatmap showing mean expression values per cluster of genes upregulated in EEP clusters during 
endocrine lineage formation. Genes were selected from (pan)endocrine, lineage- and stage-specific markers (Methods). Colour bars on the side indicate 
expression in the progenitor populations (Fig. 3a). e, Cell proportions in EEC lineage subsets from CD- and HFHSD-derived samples (mean ± s.e.m. of 
biologically independent samples, n = 3 mice per group, Dirichlet multinomial model). *Indicates a credible shift (95% highest posterior density interval 
of the frequency shift modeled by a Dirichlet multinomial model does not overlap 0). f–o, Validation of EEC frequencies in CD- and HFHSD-fed FVF mice 
by immunofluorescence staining. Representative LSM images (f) and quantification of Ngn3+ cells in isolated small intestinal crypts (g). Scale bar, 10 µm, 
n = 4 mice per group. Representative LSM images (h) and quantification of 5-HT+ cells in isolated small intestinal crypts (i). Scale bar, 10 µm, n = 4 mice 
per group. Representative LSM images (j) and quantification of Ghrl+ cells in duodenal sections (k–m). Scale bar, 100 µm; crypt, n = 5 for CD mice and 
n = 4 HFHSD mice; villus, n = 4 CD and HFHSD mice. Quantification of Gcg+ cells in ileal sections (n,o), n = 3 CD and HFHSD mice. Data are shown as 
mean ± s.e.m. of biologically independent samples. Statistical significance was determined by two-tailed Student’s t-test.
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(Extended Data Fig. 7p), suggesting that Ghrl+ EECs are func-
tionally impaired upon HFHSD. Glp-1 plasma levels were also 
increased, which corresponds with increased numbers of ileal Gcg+ 
cells (Extended Data Fig. 7q). Taken together, these results show that 
an HFHSD impacts EEPs, alters the number of specific mature EEC 
subtypes and circulating gut hormone levels and affects expression 
of genes that are potentially important for endocrine cell differen-
tiation and/or function.
HFHSD induces hyperproliferation of ISCs and progenitors. 
We next asked whether the increased number of Ngn3+ EEPs, 
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the enterocyte and goblet cell lineage under HFHSD conditions, 
resulted from enhanced proliferation. To test this, we identified 
proliferating cells using a cell-cycle signature score that assigns each 
cell to a cell-cycle state (G1, S and G2M; Methods) (Extended Data 
Fig. 8a). HFHSD mainly increased the proportion of cells in G2M 
phase, indicating that HFHSD alters cell-cycle dynamics (Fig. 4a,b). 
In particular, in ISCs, enterocytes, goblet cells and the early Sox4+ 
and Ngn3+ EEP clusters, the proportion of cycling cells was clearly 
increased (Fig. 4c and Extended Data Fig. 8b). Moreover, several 
genes, including the known cell-cycle regulators Ccnb1, Cenpa, Dut, 
Pbk and Smc2, which correlated with the S/G2M cell-cycle score, 
were differentially expressed in proliferating cells upon HFHSD, 
further suggesting that cell-cycle dynamics of ISCs and progenitors 
is accelerated (Fig. 4d and Supplementary Table 5).
To confirm the increase in proliferative activity, we first iden-
tified 5-ethynyl-2ʹ-deoxyuridine (EdU)-positive progenitor cells 
2 h after an EdU pulse. Consistent with the crypt scRNA-seq data, 
we found a higher number of proliferative progenitors in the 
transit-amplifying (TA) zone in SI crypts of HFHSD-fed FVF mice 
(Fig. 4e,f). To directly assess the number of proliferating ISCs we 
put Lgr5-ki mice33 on an HFHSD (Extended Data Fig. 8c). In con-
trast to our scRNA-seq data, we found no difference in the num-
bers of ISCs between CD and HFHSD by flow cytometry on the 
basis of high Lgr5-EGFP fluorescence intensity (Extended Data 
Fig. 8d and Fig. 4g). However, the numbers of EdU-positive ISCs 
were increased on HFHSD (Fig. 4h,i).
Further, we determined antigen immunoreactivity to Ki67 and 
the migration rate of crypt cells. We observed that Ki67-labeled 
domains were significantly larger in mice fed an HFHSD and, in 
contrast to controls, extended into the villi. Also, the crypt-to-villus 
migration rate of pulse-labeled 5-bromo-2ʹ-deoxyuridine 
(BrdU)-positive cells was increased on HFHSD (Extended Data 
Fig. 8e–i) which altogether suggests that an HFHSD enhances 
cell turnover.
In summary, these data demonstrate that an obesogenic diet 
increases the proliferation rate of ISCs and progenitors leading to 
increased villus length. Enhanced cell-cycle activity of ISCs did 
not result in physical expansion of the ISC pool due to accelerated 
differentiation and cell turnover. This is reflected by the decreased 
fraction of ISCs and increased fraction of progenitors in our crypt 
scRNA-seq data (Fig. 1e). These results further indicate that ISC 
homeostasis and identity is disturbed in HFHSD-fed animals.
HFHSD upregulates fatty acid synthesis and Ppar signalling. 
A central role of metabolic pathways in the regulation of stem cell 
maintenance and fate control has been described in several adult 
stem cell systems34,35. Both Wnt/β-catenin and Igf1/insulin sig-
nalling integrate metabolic and proliferative cues, and increased 
activity of these pathways has been shown to induce ISC hyperp-
roliferation upon high-fat diet (HFD) feeding6,36–38. We assessed 
Wnt/β-catenin pathway activation in bulk ISC-enriched FVFlow 
cells and FVFneg enterocyte progenitors, which we isolated by flow 
cytometry (Supplementary Fig. 2a,b). Unexpectedly, the level of 
nuclear β-catenin was decreased or unchanged in ISC-enriched 
FVFlow cells or enterocyte progenitor-enriched FVFneg cells, respec-
tively (Supplementary Fig. 2c,d). Consistently, expression of 
Wnt/β-catenin target genes was downregulated in ISC-enriched 
FVFlow cells and HFHSD-derived single-cell ISCs (Supplementary 
Fig. 2e–g and Supplementary Table 1). As glycogen synthase kinase 
3β (Gsk3β) is a negative regulator of Wnt/β-catenin signalling 
and an important modulator of cellular metabolism, we checked 
Gsk3β activity39. Decreased levels of phosphorylated Gsk3β in 
HFHSD-derived SI crypts indicated increased Gsk3β activity and 
enhanced Gsk3β-mediated destruction of β-catenin (Supplementary 
Fig. 2h,i). Together, these results demonstrate that Wnt/β-catenin 
signalling does not drive hyperproliferation of ISCs and progeni-
tors and enhanced progenitor recruitment in our HFHSD mouse 
model. Instead, decreased Wnt/β-catenin signalling indicates that 
differentiation of ISCs is accelerated and thus provides further evi-
dence of disturbed ISC homeostasis40,41. HFHSD caused obesity and 
hyperinsulinaemia in our mouse model. Analysis of InsrIgf1rAkt 
pathway activity in SI crypt lysates showed increased phosphoryla-
tion of InsrIgf1r and Akt as well as upregulation of several genes 
associated with PI3K and Akt signalling, which is in line with pro-
nounced hyperinsulinaemia and confirms previous findings that 
Igf1insulin signalling induces hyperproliferation in diet-induced 
obesity (Extended Data Figs. 1r–u and 9a–c).
To uncover additional metabolic pathways that link HFHSD to 
hyperproliferation and cell fate changes, we compared metabolite 
profiles from SI crypt regions of CD- and HFHSD-fed FVF mice 
using matrix-assisted laser desorption/ionization mass spectrom-
etry imaging (MALDI–MSI)42. MALDI–MSI allows analysis of 
metabolites directly in tissue sections without isolation bias. We 
identified 297 discriminative masses; of these, 257 were enriched 
and 40 were less abundant in SI crypts of HFHSD-fed animals 
(Fig. 5a). Pathway enrichment analysis revealed that HFHSD 
upregulated metabolite signatures related to fatty acid biosynthe-
sis (for example, octadecanoic acid) and linoleic acid metabolism 
(for example, phosphatidylcholine) and downregulated metabolites 
linked to pathways of glucose metabolism, such as the pentose phos-
phate pathway and pentose glucuronate interconversions (for exam-
ple, d-glyceraldehyde 3-phosphate) (Fig. 5b and Supplementary 
Table 6). To map the metabolic changes from tissue to cell-type 
level, we integrated metabolomics data with bulk transcriptomes 
of ISC-enriched FVFlow cells, secretory progenitor-enriched FVFhigh 
cells and enterocyte progenitor-enriched FVFneg cells (Extended 
Fig. 4 | HFHSD induces hyperproliferation of ISCs and progenitors. a, Distribution of cycling cells across CD- and HFHSD-derived cell clusters depicted  
as cell densities projected onto the UMAP plot and quantified as proportions of cells in each cell-cycle stage. Cells were classified using a cell-cycle  
score, calculated using the expression of genes related to cell cycle. Data are mean ± s.e.m. of biologically independent samples, n = 3 mice per group.  
b, Distribution of ISCs and progenitors over the three cell-cycle stages visualized as cell densities in a scatter-plot of S- versus G2/M-phase score levels. 
Higher score levels indicate higher expression of involved genes. Dotted lines depict classification borders. Densities are Gaussian kernel estimates.  
c, Proportions of cycling cells in CD and HFHSD-derived ISCs and progenitor clusters. Table indicates percentages. Data are shown as mean ± s.e.m. of 
biologically independent samples, n = 3 mice per group. EP, enterocyte progenitor; GP, goblet progenitor. d, Heatmap of mean expression values per cluster 
of selected genes used for cell-cycle scoring (black) or highly correlating with S and G2M scores (grey, Pearson correlation >0.7). Only cells classified as 
cycling (S or G2M phase) are shown. * Indicates differentially expressed genes between CD and HFHSD conditions (two-sided, limma, adjusted P < 0.01, 
logFC > 0.1), n = 3 mice per group. FC, fold change. P values are provided in Supplementary Table 5. e,f, Representative LSM images (e) and quantification 
(f) of EdU incorporation after a 2-h EdU (white) pulse in the TA zone in duodenal sections of CD- and HFHSD FVF mice. Lyz1+ Paneth cells are shown 
in red. Scale bar, 25 µm, n = 4 mice per group. Data are mean ± s.e.m. of biologically independent samples. Statistical significance was determined by 
two-tailed Student’s t-test. FDR, false discovery rate. g, Determination of Lgr5–EGFPhi cells from CD- and HFHSD-fed Lgr5-ki mice by flow cytometry,  
n = 4 mice per group. Data are mean ± s.e.m. of biologically independent samples. h,i, Representative LSM images from cytospin (h) and quantification  
(i) of EdU+Lgr5–EGFPhi cells from CD- and HFHSD-fed Lgr5-ki mice after a 2-h EdU (white) pulse. Scale bar, 40 µm, n = 4 CD mice, n = 3 HFHSD mice. 
Data are mean ± s.d. of biologically independent samples. Statistical significance was determined by two-tailed Student’s t-test.
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Data Fig. 9d, Fig. 5c and Methods). The HFHSD metabolite sig-
nature overlapped with regulated genes involved in carbohydrate 
metabolism (for example, sucrose degradation, maturity onset 
diabetes of young (MODY) signalling) and pro-proliferative 
fatty acid biosynthesis pathways (for example, stearate synthesis 
and acyl-CoA-hydrolysis)43. Regulation of these pathways was 
most pronounced in enterocyte progenitor-enriched FVFneg and 
ISC-enriched FVFlow cells (Fig. 5d and Supplementary Table 7). 
Next, to determine the cell subtypes in which an HFHSD altered 
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deregulated HFHSD metabolites, we compared the transcriptional 
profiles of CD- and HFHSD-derived cells. We found that gene 
signatures associated with Ppar signalling (for example Hmgcs2, 
Acdvl, Acaa2, Fabp1 and Fabp2) and fatty acid biosynthesis (for 
example Acot1, Acox1, Scd2, Srebf1, Fads1 and Me1) were upregu-
lated in HFHSD-derived ISCs and progenitor clusters (Fig. 5e–g  
and Supplementary Tables 1,8 and 9). Upregulation of these gene 
sets was stronger in subpopulations with proximal identity; in 
particular, in proximal ISCs, enterocyte and goblet progenitors 
(Fig. 5e,f and Supplementary Table 8). Moreover, genes associated 
with carbohydrate metabolism (for example glycolysis, gluconeo-
genesis and the pentose phosphate pathway) were downregulated 
in these subtypes (Fig. 5e–g). We confirmed upregulation of active 
Srebp1 (mature, m-Srebp1), Acc, Pparγ and Scd1, the master tran-
scriptional regulators and key enzymes of Ppar signalling and fatty 
acid synthesis in HFHSD crypt protein lysates and in ISCs and 
progenitors, by a sensitive, targeted single-cell qPCR approach 
(Fig. 5h,i, Extended Data Fig. 10 and Supplementary Table 10). 
Finally, consistent with crypt enterocytes, we also found that mature 
villus enterocytes increase the expression of genes associated with 
intracellular fat accumulation and lipid uptake, de novo lipogenesis 
and peroxisomal fatty acid oxidation (Supplementary Fig. 3).
Thus, by integration of in situ metabolomics, bulk and 
single-cell transcriptomics and targeted protein expression analy-
sis, we have revealed diet-induced metabolic rewiring and cell- and 
subtype-specific transcriptional changes that correlate with an 
increase in proliferation and endocrine dysfunction.
Discussion
In this study we provide a basic mechanistic explanation of 
diet-induced ISC dysfunction and intestinal maladaptation that 
underlie the development of obesity and prediabetes and increase 
the risk for gastrointestinal cancer.
With our study we aimed to determine the immediate effects of a 
western-style HFHSD on intestinal function. We observed enlarge-
ment of the SI, longer villi and decreased crypt density and an altered 
cellular composition in the crypts, which was confirmed in the villi 
by lineage-tracing studies. We are aware that our lineage-tracing 
approach using the dual-fluorescent, inducible Cre-reporter Foxa
2nEGFP-CreERT2/+;Gt(ROSA)26mTmG/+ mouse has its limitations; for exam-
ple, inefficient labelling of stem cells, which generates fewer clonal 
ribbons in comparison to the Lgr5-ki reporter33 and analysis of only 
one time point. Therefore, we validated our findings from the crypt 
scRNA-seq experiment not only by a lineage-tracing approach but 
also independent of a reporter in tissue sections.
We show that ISCs and progenitors are hyperproliferative, and 
that differentiation and cell turnover are accelerated by an HFHSD. 
Accelerated differentiation and cell turnover also explain the 
discrepancy between the scRNA-seq data (decrease in ISCs) 
and the data from the Lgr5-reporter mice (no change in the 
number of ISCs). ISCs in HFHSD-fed mice divide faster and newly 
formed cells are still Lgr5–EGFPhi, but already express markers of 
differentiated cells. Whole-transcriptome-based clustering in our 
scRNA-seq data groups Lgr5hi ISCs and Lgr5hi progenitors sepa-
rately, whereas when using only Lgr5–EGFP as a marker in tissue 
sections and flow cytometry we cannot discriminate between an 
ISC and a progenitor.
Hyperproliferation in the crypt, which can promote cancer initi-
ation and progression, has previously been associated with an HFD; 
however, the molecular pathways that couple dietary cues to this 
cellular response are still debated and probably depend on the type 
of diet (for example fat and sugar source)37,38,44. Also, a role of meta-
bolic pathways in ISC maintenance, number and fate control has 
been highlighted in several studies7,44,45. Hyperproliferation upon 
HFHSD is not driven by Pparδ-mediated activation of the major 
oncogenic pathway in the gut, Wnt/β-catenin signalling, as previ-
ously reported for a lard-based chronic HFD6,46,47. Instead, we found 
that a coconut oil- and sucrose-based high-lipid and -carbohydrate 
content diet specifically elevates pro-proliferative Pparγ signal-
ling, Srebp1-mediated lipogenesis and InsrIgf1r–Akt signalling. 
Upregulation of Pparγ and Srebp1-mediated de novo lipogenesis 
has been associated with inflammation, increased proliferation 
and tumour progression in many types of cancer and thus provides 
a possible link between HFHSD-induced metabolic signalling, 
crypt-cell hyperproliferation and increased risk of gastrointestinal 
cancer43. As tumour initiation and progression require biomass pro-
duction and therefore depend on a high nutrient supply, chronic 
activation of these pathways as observed with an HFHSD might 
reduce the barrier to oncogenic transformation or tumour growth 
and proliferation.
Further, we found a profound impact of an HFHSD on the 
enterocyte lineage. Enterocytes are metabolically rewired, increase 
the expression of genes linked to carbohydrate and fat uptake and 
show an intracellular fat accumulation, which is reminiscent of 
the vesicular accumulation of triglycerides in hepatic steatosis that 
causes liver fibrosis and cancer48–50. In addition, HFHSD induces 
a regional and spatial repatterning of enterocyte gene expression 
and function. An HFHSD increased the number of proximal-type 
enterocytes, which are specialized on carbohydrate and fatty acid 
absorption and altered enterocyte zonation along the crypt–vil-
lus axis (increased expression of the fatty acid transporter Fabp1). 
Thus, our results imply that enterocytes functionally adapt to an 
HFHSD, which may increase calorie intake and fat accumulation 
and promote obesity.
Fig. 5 | Fatty acid synthesis and Ppar signalling are upregulated on HFHSD. a, Heatmap-based clustering analysis of the 297 discriminative metabolite 
masses (FC ≥ 2 and P ≤ 0.05). Each coloured cell on the map corresponds to an intensity value, with samples in rows and features in columns. Euclidean 
distance and Ward’s method were applied for clustering analysis. Statistical significance was determined by two-tailed Student’s t-test. b, Pathway 
enrichment analysis of deregulated metabolites was performed with MetaboAnalyst 3.0. The enrichment method was hypergeometric test. Topology 
analysis was based on relative betweenness centrality. The P value was calculated from the enrichment analysis without adjustment (FC ≥ 2 and P ≤ 0.05). 
Metabolic pathways are represented as circles according to their scores from enrichment (vertical axis) and topology analyses (pathway impact, 
horizontal axis). c, Overview of experimental design for data integration. d, Ingenuity pathway analysis showing overlap of significantly deregulated 
metabolites on HFHSD from MALDI–MSI profiling and genes from microarray analysis. Shown are values from microarray analysis and the red line 
indicates the significance cutoff. e, Enriched KEGG pathways in genes differentially regulated between CD and HFHSD conditions (Enrichr, Fisher’s exact 
test, two-sided). Genes with FDR < 0.01 and logFC > 0.1 were considered and weighted by logFC. f, Volcano plots showing differential expression and its 
significance (−log10(FDR), limma) for each gene on HFHSD compared to CD. Red lines indicate thresholds used for significance level and gene expression 
change and regulated genes are highlighted in black. Annotated genes are the top ten genes ranked by FDR. g, Mean expression levels for selected genes. 
* Indicates a significant change (limma, FDR < 0.01, logFC > 0.1). h,i, Protein expression analysis by western blot in cytoplasmic (cyto) and nuclear (nucl) 
extracts from SI crypts of CD- and HFHSD-fed FVF mice. Representative immunoblots (h) and relative quantification of band signal intensity (i), n = 4 mice 
per group (Srebp1, Scd1, Acc, Fasn) and n = 7 mice per group (Pparγ). Data are presented as box-and-whisker plots. The lower and upper boundaries of 
the boxes represent the 25th and 75th percentiles, respectively. The centre lines indicate the medians and whiskers represent the maximum and minimum 
values. Statistical significance was determined by two-tailed Student’s t-test. Circles represent biological independent samples. norm., normalized.
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Our in-depth molecular and functional analysis of the EEC 
lineage reveals mechanisms of EEC dysfunction in obesity that 
include (1) higher abundance of Ngn3+ EEPs owing to increased 
proliferation, (2) lower abundance of serotonergic Reg4+ EC cells 
and lower plasma serotonin levels, (3) higher abundance of peptide-
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numbers of ileal Gcg+ cells and increased Glp-1 levels and (5) lower 
abundance of Lgr5+ EECs. The physiological roles of gut-derived 
serotonin are broad and it regulates various processes both in the gut 
and systemically32. Accumulating evidence indicates a link between 
peripheral serotonin and systemic glucose and lipid metabolism, 
as well as metabolic diseases51. Whether blood serotonin levels are 
changed in obesity is controversial, due to difficulties in measur-
ing serotonin51. However, intraperitoneal injection of 5-HT to mice 
inhibits weight gain, hyperglycaemia and insulin resistance on an 
HFD52. Thus, reduced numbers of serotonin-producing cells and 
blood serotonin levels as observed in our mouse model might pro-
mote the development of obesity. The hunger hormone ghrelin is 
known to increase gastric emptying and decrease insulin secre-
tion53. A negative correlation between plasma insulin and ghrelin 
has been reported in human obesity, which is in line with our data54. 
Notably, we found that lower plasma ghrelin levels are not due to a 
reduced number of Ghrl+ SILA cells, suggesting that an impaired 
secretory machinery might affect ghrelin levels. However, given that 
ghrelin-secreting cells are also present in the stomach, changes in 
plasma ghrelin levels may not be solely attributed to duodenal Ghrl+ 
EECs. Lower postprandial GLP-1 levels are reported in obesity and 
incretin hormone secretion and activity are impaired in individu-
als with prediabetes, although findings are contradictory9,55. In our 
obesity model, however, the number of Gcg-expressing cells and 
Glp-1 plasma levels were increased. Glp-1 stimulates insulin secre-
tion from pancreatic β-cells, so the higher levels of circulating Glp-1 
in HFHSD-fed mice may be a compensatory response to insulin 
resistance at the prediabetic state, which leads to hyperinsulinaemia.
Finally, in contrast to other studies, Paneth cell numbers were 
not affected in our obesity model6.
The discrepancies between our results and those of previous 
studies support the emerging evidence that the intestine fine-tunes 
its response to environmental stimuli6,37,38. Different factors, such 
as the selected mouse model (for example, diet versus genetically 
induced obesity), type of diet (for example HFD versus HFHSD), 
fat source (for example lard versus coconut oil) and/or duration of 
diet (short-term versus chronic) can influence intestinal remod-
elling and response. For instance, in contrast to the coconut oil, 
high-sucrose diet for 12–14 weeks used in this study, a lard-based 
low-sugar chronic diet for 9–14 months caused shorter villi, 
increased the number of ISCs, decreased the number of Paneth cells 
and did not affect goblet cells and EECs6. Hence, careful selection 
and reporting of dietary information in animal studies is crucial to 
interpret and contextualize results.
In summary, our study reveals that functional maladaptation of 
the gut in response to an HFHSD is caused by disturbed ISC iden-
tity, changes in the regional identity of cells and an altered mature 
cell-type composition. Further, we describe targetable pathways 
that are induced by an HFHSD and potentially underlie the patho-
genesis of the metabolic syndrome and gastrointestinal cancer. 
This new understanding of the mechanisms of disease is crucial 
to develop non-invasive therapeutic options to resolve obesity and 
insulin-dependent diabetes, for example by counteracting entero-
endocrine dysregulation (for example, by elevating peripheral 
serotonin levels) and increased nutrient absorption (for example, 
by inducing distal enterocyte phenotypes).
Methods
Experimental model. Animals. Animal experiments were carried out in 
compliance with the German Animal Protection Act and with the approved 
guidelines of the Society of Laboratory Animals and of the Federation of 
Laboratory Animal Science Associations. This study was approved by the 
institutional Animal Welfare Officer (Helmholtz Center Munich) and by 
the Government of Upper Bavaria, Germany. Homozygous FVF mice were 
generated as previously described and backcrossed to C57BL/6 background22. 
Foxa2nEGFP-CreERT2 mice25 (CD1 background) were crossed with Gt(ROSA)26mTmG 
mice24 (mixed 129/SvJ, C57BL/6J background) to obtain heterozygous Fo
xa2nEGFP-CreERT2/+;Gt(ROSA)26mTmG/+ animals and bred in our own facilities. 
Other mouse lines were Lgr5-EGFP-IRES-creERT2 (ref. 33) (Lgr5-ki, C57BL/6J 
background) and wild-type C57BL/6N (bred in our own facilities).
Mice were housed in groups of two to four animals and maintained at 23 ± 1 °C 
and 45–65% humidity on a 12-h dark/light cycle with ad libitum access to diet 
and water unless otherwise indicated. All experiments were performed using male 
animals at 3 to 7 months of age.
Dietary interventions. For dietary interventions, 10–12-week-old male mice were 
randomized into test groups matched for body weight, with similar variance, and 
given ad libitum access to either an obesogenic HFHSD (58% kcal from fat, 25% 
kcal from carbohydrates, 17% kcal from protein (Research Diets, no. D12331)) 
or CD (11% kcal from fat, 64% kcal from carbohydrates, 25% kcal from protein 
(ssniff Spezialdiäten, E15051-04)) for a period of 11–13 weeks. Body weights were 
measured every second week.
Body composition analysis. Lean and fat masses were measured in FVF mice 
12 weeks after the start of the diet using quantitative nuclear magnetic resonance 
technology (EchoMRI).
Glucose tolerance and insulin secretion tests. Glucose tolerance was assessed by 
an oral glucose tolerance test (oGTT) in FVF mice, maintained for 12 weeks on 
CD or HFHSD. After a 6-h fast, mice received an oral glucose bolus (1.5 mg g−1 
body weight of 20 % (wt/v) d-(+)-glucose (Sigma-Aldrich) in PBS). Tail blood 
glucose concentrations were measured with a handheld glucometer (Abbott) before 
(0 min) and 15, 30, 60 and 120 min after the glucose bolus. To measure the insulin 
secretion, tail vein blood samples were collected into EDTA-coated microvette 
tubes (SARSTEDT) at time points 0, 15 and 30 min of the oGTT. Plasma was 
extracted by centrifugation (3,500 r.p.m., 15 min, 4 °C) and insulin concentration 
was determined using the Ultra-Sensitive Mouse Insulin ELISA Kit (Crystal Chem, 
90080) according to the manufacturer’s instructions.
The homeostasis model assessment of insulin resistance (HOMA-IR) and 
HOMA-β were used to assess insulin resistance and beta-cell function, respectively, 
in FVF mice at 12 weeks after diet start. HOMA indices were calculated from basal 
blood glucose and plasma insulin levels after a 6-h fast based on the conventional 
formulas: HOMA-IR = fasting blood glucose (mg per 100 ml) × fasting insulin 
(µU per ml)/405 and HOMA-β = fasting insulin (µU per ml) × 360/fasting glucose 
(mg per 100 ml) − 63 (ref. 56).
Plasma hormone measurements. Circulating hormones, serotonin, ghrelin 
and Glp-1 were assessed in FVF mice maintained for 13 weeks on a CD or an 
HFHSD. For basal levels (ghrelin and serotonin), mice were fasted for 6 h and tail 
vein blood was sampled into EDTA-coated microvette tubes (SARSTEDT). To 
compare postprandial plasma hormone levels (Glp-1, ghrelin), fasted mice were 
gavaged with 250 µl of mixed-meal-containing liquid diet (Osmolite HiCal, Abbott) 
supplemented with dextrose at 20% (wt/v) (Sigma-Aldrich). Blood was collected 
10 min after the mixed-meal bolus either from the tail vein or, under terminal 
anaesthesia with isoflurane, from the vena cava57–59. For Glp-1 measurement, blood 
samples were immediately mixed with 0.1 mM Diprotin A (Abcam, 145599) and 
500 KIU ml−1 aprotinin (Sigma, A-1153). Plasma was extracted by centrifugation 
(13,000 r.p.m., 2 min, 4 °C). Total ghrelin concentrations were determined using an 
ELISA kit from Millipore-Merck (EZRGRT-91K), total plasma Glp-1 was measured 
using a mouse Glp-1 ELISA kit (Crystal Chem, 81508) and serotonin concentration 
was determined using a serotonin ELISA kit from Enzo (ADI-900-175).
Proliferative cell labelling with EdU and BrdU and tamoxifen administration 
in mice. To assess the epithelial replication rate in the SI, EdU (Thermo 
Fisher Scientific, A10044) or BrdU (Sigma, no. B5002) was administered as an 
intraperitoneal injection at 100 μg g−1 body weight or at 50 μg g−1 body weight, 
respectively, each from a 10 mg ml−1 stock and in sterile PBS. Mice were killed 
2 h post-EdU or 24 h post-BrdU administration. For the assessment of BrdU 
label retention, FVF mice maintained for 10 weeks on a diet were given BrdU in 
drinking water at 1 mg ml−1 supplemented with 1% sucrose for 14 d. BrdU was 
then withdrawn and mice were further maintained on a diet with ad libitum 
drinking water for a chase period of 21 d. A group of mice was killed after 14 d of 
continuous BrdU labelling or after a 21d period of chase. For short-term genetic 
lineage studies, Foxa2nEGFP-CreERT2/+;Gt(ROSA)26mTmG/+ mice were fasted for 3 h 
and Cre-recombinase activity was induced by a titrated single dose of tamoxifen 
administered orally by gavage (Sigma-Aldrich, T5648) at 0.25 mg g−1 body weight 
in sunflower oil. Mice were killed 70 h after the tamoxifen gavage.
Crypt and villus isolation and single-cell preparation. Isolation of small 
intestinal crypts was carried out as previously reported60. In brief, SIs were removed 
and washed with cold PBS. Villi were scraped off with a glass slide. The remaining 
tissue was cut into 2-cm pieces, washed several times with cold PBS and incubated 
in 2 mM EDTA/PBS for 35 min at 4 °C on a tube roller. Subsequently, crypts were 
collected by rigorous shaking and filtered through a 70-µm mesh to remove villous 
fragments. For single-cell preparation, isolated crypts were incubated with TrypLE 
(Life Technologies, no. 12605) for 5 min on ice and then 5 min at 37 °C and treated 
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with 10 µg ml−1 DNase in crypt complete medium (DMEM/F-12 containing 10% 
FCS) for 5 min at 37 °C. Single-cell suspension was achieved by gentle repeated 
pipetting. Cells were washed twice with 2% FCS in PBS and pelleted at 300g for 
5 min at 4 °C. For flow cytometry, cells were collected in 1–2 ml FACS buffer  
(2% FCS, 2 mM EDTA in PBS) (Sigma-Aldrich, no. Y0503) and passed through 
40-µm cell strainer caps of FACS tubes.
To obtain a single-cell suspension of villi cells, villi were scraped off and 
incubated with TrypLE as described for crypt cells.
Flow cytometry. For gene expression measurement (microarray, single-cell 
transcriptomics) and western blotting, small intestinal crypt cells were sorted 
using FACS-Aria III (FACSDiva software v.6.1.3, BD Bioscience) with a 100-µm 
nozzle. For all experiments, single cells were gated according to their FSC-A (front 
scatter area) and SSC-A (side scatter area). Singlets were gated dependent on 
the FSC-W (front scatter width) and FSC-H (front scatter height) and dead cells 
were excluded using 7-AAD (eBioscience, no. 00-6993-50). For quantitative PCR 
with reverse transcription (qRT–PCR), cells were sorted directly into Qiazol lysis 
reagent (QIAGEN, no. 79306). To obtain FVF-enriched small intestinal crypt-cell 
samples for scRNA-seq, we sorted 30,000 FVF+ (FVFlow and FVFhigh) cells followed 
by sorting 30,000 live crypt cells per sample. Cells were sorted into modified FACS 
buffer (2% FCS, 0.02 mM EDTA in PBS).
RNA isolation for qRT–PCR and microarray. For bulk gene profiling studies 
(qPCR, microarray), RNA isolation from crypts or flow-sorted cells was 
performed using the RNA isolation kit miRNeasy Mini (QIAGEN, no. 217004) 
or miRNeasy Micro kit (QIAGEN, no. 217084) depending on the amount of the 
sample. Complementary DNA was synthesized using the SuperScript VILO cDNA 
synthesis kit (Invitrogen, no. 11754). RNA was reverse transcribed and amplified 
with the Ovation PicoSL WTA System V2 kit (NuGEN, no. 331248).
Microarray analysis. For gene profiling of flow-sorted FVFlow, FVFhigh and FVFneg 
cells from CD- and HFHSD-fed FVF mice, total RNA was isolated as described 
above and RNA integrity was assessed using an Agilent 2100 Bioanalyzer (Agilent 
RNA 6000 Pico Kit). RNA was amplified with the Ovation PicoSL WTA System 
V2 in combination with the Encore Biotin Module (Nugen). Amplified cDNA 
was hybridized on Affymetrix Mouse Gene 1.0 ST arrays. Staining (Fluidics script 
FS450_0007) and scanning of the microarray were performed according to the 
Affymetrix expression protocol including minor modifications as suggested in the 
Encore Biotin kit protocol. Expression Console (v.1.3.0.187, Affymetrix) was used 
for quality control and annotation of the normalized robust microarray analysis 
gene-level data, and standard settings, including median polish and sketch-quantile 
normalization, were used.
TaqMan qRT–PCR. For gene expression analysis, real-time qRT–PCR was 
performed using TaqMan probes (Life Technologies), TaqMan Fast Advanced 
Master Mix (Applied Biosystems, no. 4444557) or TaqMan Universal Master Mix II 
(Applied Biosystems, no. 4440040) for amplified cDNA and the ViiA 7 Real-Time 
PCR System (Thermo Fisher Scientific).
The following probes were used: Mm00782745_s1 for Rpl37, Mm00438890_m1 
for Lgr5, Mm01320260_m1 for Olfm4, Mm01268891_g1 for Ascl2, Mm00443610_
m1 for Axin2, Mm03928990_g1 for RN18S, Mm02524776_s1 for Fzd2, and 
Mm00433409_s1 for Fzd7.
scRNA-seq: RNA preparation, library generation and sequencing. FVF-enriched 
single-cell samples of crypts isolated from the small intestinal epithelium 
(duodenum, jejunum and ileum) and villus samples from the SI of C57BL/6N mice 
were prepared as described above. Dead cells were excluded by flow cytometry 
after 7AAD labelling. Dead cell exclusion was controlled by trypan blue staining 
and sorted cells were counted. Single-cell libraries were generated using the 
Chromium Single cell 3′ library and gel bead kit v2 (10X Genomics, no. 120237) 
according to the manufacturer’s instructions. Libraries were sequenced on a 
HiSeq4000 (Illumina) with 150-bp paired-end sequencing of read 2.
MALDI–MSI. Fresh-frozen samples were cut into 12-μm sections using a 
cryo-microtome at −20 °C (Leica CM1950, Leica Microsystems) and mounted 
onto precooled conductive indium-tin-oxide-coated MALDI target glass slides 
(Bruker Daltonics). Sections were coated with 9-aminoacridine hydrochloride 
monohydrate matrix (Sigma-Aldrich) at 10 mg ml−1 in water/methanol 30:70 
(v/v) by a SunCollect automatic sprayer (Sunchrom). The matrix application was 
performed at flow rates of 10, 20 and 30, respectively, for the first three layers.  
The other five layers were performed at 40 μl min−1. MALDI–MSI measurement 
was performed on a Bruker Solarix 7T FT-ICR-MS (Bruker Daltonics). MALDI–
MSI data were acquired over a mass range of m/z 50–1,000 in negative ionization 
mode with 30-μm spatial resolution using 50 laser shots at a frequency of 500 Hz. 
The acquired data underwent spectrum processing in FlexImaging v.4.2 (Bruker 
Daltonics). Following MALDI imaging experiments, the matrix was removed  
with 70% ethanol. Tissue sections were stained with haematoxylin and eosin.  
Slides were scanned with a MIRAX DESK digital slide-scanning system  
(Carl Zeiss MicroImaging).
Western blot. For protein expression analyses, whole-cell lysates from isolated 
crypts or flow-sorted cells were prepared using the RIPA buffer (50 mM Tris, pH 
7.5, 150 mM NaCl, 1 mM EDTA, 1% Igepal, 0.1% SDS, 0.5% sodium deoxycholate) 
containing phosphatase (Sigma-Aldrich, P5726, P0044) and proteinase inhibitors 
(Sigma-Aldrich, P8340). Nuclear and cytosolic extracts from isolated crypts 
were prepared using the NE-PER Nuclear and Cytoplasmic Extraction Reagents 
kit (Thermo Fisher Scientific, no. 78833) according to the manufacturer’s 
instructions. Cell lysates were mixed with Laemmli sample buffer, resolved by 
SDS–PAGE and blotted onto a PVDF membrane (Bio-Rad). Membranes were 
blocked with 5% milk in Tris-buffered saline containing 0.2% Tween-20, then 
incubated overnight with primary antibodies in blocking solution at 4 °C, followed 
by a 1-h incubation with horseradish peroxidase (HRP)-conjugated IgG secondary 
antibodies. Protein bands were visualized using a chemiluminiscence reagent 
(Bio-Rad, no. 170-5061) and quantified using ImageJ software. For quantification, 
expression of proteins was normalized to α-tubulin or lamin in cytoplasmic or 
nuclear fractions, respectively.
Primary antibodies used were mouse anti-Srebp1 (1:1,000 dilution, 
Novus Biologicals, NB600-582SS); rabbit anti-Acc (1:1,000 dilution, Cell 
Signaling Technology, 3676); rabbit anti-Pparγ (1:1,000 dilution, Cell Signaling 
Technology, 2435); goat anti-lamin (1:1,000 dilution, Santa Cruz, sc-6217); mouse 
anti-α-tubulin (1:1,000 dilution, Sigma-Aldrich, T6199); rabbit anti-Fasn (1:1,000 
dilution, Cell Signaling Technology, 3180); rabbit anti-Scd1 (1:1,000 dilution, 
Cell Signaling Technology, 2794); mouse anti-β-catenin (1:1,000 dilution, BD, 
610154), rabbit anti-Gsk3β (1:5,000 dilution, Cell Signaling Technology, 12456); 
and rabbit anti-phospho Gsk3β (1:5,000 dilution, Cell Signaling Technology, 5558). 
Secondary antibodies used were goat anti-mouse HRP (1:15,000 dilution, Dianova, 
115036062); goat anti-rabbit HRP (1:15,000 dilution, Dianova, 111036045) or 
rabbit anti-goat HRP (1:15,000 dilution, Dianova, 305035045).
Tissue morphology assessment. For tissue histology, intestines were flushed and 
fixed in 4% paraformaldehyde (PFA) overnight, paraffin embedded according 
to standard procedures and sectioned at 6 µm. Sections were dried, dehydrated 
through a graded ethanol series and cleared in xylene. Standard haematoxylin and 
eosin staining was performed and images were acquired using the Zeiss AXIO 
Scope A1 microscope (Carl Zeiss AG).
Histochemistry and immunofluorescence. SIs were isolated, rinsed with ice-cold 
PBS and fixed with 4% PFA for 3 h at 4 °C. Tissue was cryopreserved through a 
progressive sucrose gradient (7.5% for 1 h, 15% for 1 h, 30% sucrose overnight), 
embedded in a tissue-freezing medium (Leica Biosystems, no. 14020108926) and 
sectioned at 14 µm. For whole-mount staining, isolated small intestinal crypts were 
fixed in 4% PFA for 30 min at room temperature (RT) and subsequently washed 
in PBS. For immunofluorescence staining, sections or crypts were permeabilized 
with 0.5% Triton X-100 in PBS for 30 min at RT, blocked (10% FCS, 0.1% BSA and 
3% donkey serum in PBS/0.1% Tween-20) for 1 h and incubated with primary 
antibodies overnight at 4 °C. Sections or crypts were washed in PBS/0.1% Tween-
20 and incubated with secondary antibodies in blocking solution for 1 h at RT, 
stained with DAPI (ROTH, 6335.1) to visualize the nuclei and mounted with the 
Elvanol antifade reagent.
To assess proliferation, EdU staining was performed using the Click-iT Staining 
kit (Invitrogen, no. C10340) according to the manufacturer’s instructions.
For BrdU staining, sections were incubated with 3.3 N HCl for 10 min on ice, 
followed by incubation for 50 min at 37 °C and two wash steps with borate buffer, 
pH 8.5, to neutralize the reaction (each wash 15 min at RT).
Ki67 immunoreactivity was assessed on paraffin tissue sections after 
heat-induced antigen retrieval (at ~90 °C, 10 min) using the Antigen Unmasking 
Solution, Citric Acid-Based (Vector Laboratories, no. H-3300-250).
Fluorescent images were obtained with a Leica SP5 confocal microscope 
(Leica Microsystems) and analysed using LAS AF software (LAS AF software 
v.2.6.0-7266).
The primary antibodies used were chicken anti-GFP (1:600 dilution, Aves Labs, 
GFP-1020); goat anti-ChgA (1:200 dilution, Santa Cruz, sc-1488); rabbit anti-Lyz1 
(1:1,000 dilution, DAKO, M0776); rabbit anti-Muc2 (1:1,000 dilution, Santa Cruz, 
sc-7314); rat anti-BrdU (1:200 dilution, Abcam, ab6326); rabbit anti-5-HT (1:1,000 
dilution, Neuromics, RA20080); anti-rabbit Ngn3 (1:100 dilution, a kind gift from 
H. Edlund); goat anti-villin (1:200 dilution, Santa Cruz, sc-7672); goat anti-ghrelin 
(1:200 dilution, Santa Cruz, sc-10368); rabbit anti-Ki67 (1:200 dilution, Abcam, 
ab15580); rabbit anti-E-cadherin (extracellular domain) (1:1,000 dilution, a gift 
from D. Vestweber); rabbit anti-Fabp1 (1:300 dilution, Abcam, ab222517); and 
rabbit anti-Apoa4 (1:300 dilution, Abcam, ab231660). The secondary antibodies 
used were donkey anti-chicken Alexa Fluor 488 (1:800 dilution, Dianova, 
703225155); donkey anti-mouse Cy5 (1:800 dilution, Dianova, 715175151); donkey 
anti-goat Alexa Fluor 555 (1:800 dilution, Invitrogen, A21432); donkey anti-rabbit 
Alexa Fluor 555 (1:800 dilution, Invitrogen, A31572); and donkey anti-rabbit Alexa 
Fluor 649 (1:800 dilution, Dianova, 711605152).
RNAScope in situ hybridization for detection of target RNA. In situ detection of 
FOXA2, LGR5 and OLFM4 mRNA was performed using the RNAscope Intro Pack 
for Multiplex Fluorescent Reagent Kit v2-Mm (ACD; no. 323136) according to the 
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manufacturer’s protocol. RNAscope 3-Plex Negative Control Probe (dapB; ACD; 
no. 320871) and RNAscope 3-Plex Positive Control Probe (ACD; no. 320881) 
were used as internal controls. Probes used were Mm-Foxa2 (ACD; no. 409111), 
Mm-Olfm4-C2 (ACD; no. 311831-C2) and Mm-Lgr5-C3 (ACD; no. 312171-C3) 
with respective fluorescent dyes Opal 520 Reagent (AKOYA; no. FP1487001KT) 
for channel 1, Opal 570 Reagent (AKOYA; no. FP1488001KT) for channel 2 and 
Opal 690 Reagent (AKOYA; no. FP1497001KT) for channel 3, diluted 1:800 in 
RNAscope Multiplex TSA Buffer (ACD; no. 322809). The assay was performed 
on FFPE mouse intestinal jejunum sections prepared as described above with a 
thickness of 7 µm and standard pretreatment conditions with protease III (ACD; 
no. 322340) as recommended by the manufacturer.
After completion of the RNAscope assay, sections were stained using DAPI 
(ROTH, 6335.1) to visualize the nuclei, washed with PBS three times and mounted 
with ProLong Diamond Antifade Mountant (Life Technologies; no. P36970). 
Samples were visualized using a Leica SP5 confocal microscope (LAS AF software 
v.2.6.0-7266).
Gene expression analysis from bulk sorted cells. Statistical bulk transcriptome 
analyses were performed using the statistical programming environment R 
implemented in CARMAweb61,62. Gene-wise testing for differential expression was 
carried out employing the limma t-test. Sets of regulated genes were defined by 
raw P < 0.01, FC > 1.3× and average expression in at least one group >32. Enriched 
canonical pathways were analysed through the use of QIAGEN’s ingenuity pathway 
analysis (https://www.qiagen.com/ingenuity). Microarray data are available at Gene 
Expression Omnibus (GEO).
Bioinformatics and statistical analysis of MALDI–MSI data. MATLAB R2014b 
(v.7.10.0, Mathworks) was used as MALDI spectral pre-processing tool for the 
subsequent data bioinformatics analysis. Peak picking was performed using an 
adapted version of the LIMPIC algorithm63. In brief, the parameters of peak 
picking included m/z 0.0005 minimal peak width, signal-to-noise threshold 
of 4 and intensity threshold of 0.01%. Isotopes were automatically identified 
and excluded. Statistical comparisons were performed with a Student’s t-test 
(two-tailed). Metabolites were considered to be significant if they had an intensity 
FC ≥ 2 and a P value ≤0.05. Metabolite annotation was performed by matching 
accurate mass with databases (mass accuracy ≤4 ppm, METLIN, http://metlin.
scripps.edu/; Human Metabolome Database, http://www.hmdb.ca/; MassTRIX, 
http://masstrix3.helmholtz-muenchen.de/masstrix3/; METASPACE, http://
annotate.metaspace2020.eu/). Heat-map-based clustering and enrichment analysis 
of metabolic pathways were performed with MetaboAnalyst v.3.0 (http://www.
metaboanalyst.ca).
Integration of bulk transcriptome and metabolome. Lists of genes participating 
in the candidate pathways from the ingenuity canonical pathways analysis of the 
microarray data of FVFlow, FVFhigh and FVFneg cells were compiled. For each of the 
genes on the lists, information on the reaction it is involved in and the participating 
metabolites were extracted from the mouse specific BiGG databank (https://www.
ncbi.nlm.nih.gov/pmc/articles/PMC2874806/, https://www.ncbi.nlm.nih.gov/
pubmed/20959003). If genes and metabolites within a reaction were also significant 
in their analyses as described above, the reaction and its pathway were said to be 
affected at both the metabolomics and the transcriptomics levels.
Single-cell gene expression analysis by microfluidic qRT–PCR. To assess the 
transcriptional profiles of single FVFlow and FVFhigh cells, a nested single-cell 
qPCR design was used. FVFlow or FVFhigh cells isolated from three CD- and 
HFHSD-fed FVF mice were sorted as described above directly into single wells of 
96-well plates containing 5 μl of a pre-amplification solution composed of 1.2 μl 
5× VILO reaction mix (Invitrogen, no. 11754-050), 0.3 μl 20 U μl−1 SUPERase-In 
(Ambion, no. AM2694), 0.25 μl 10 % NP40 (Thermo Fisher Scientific, no. 28324), 
0.25 μl RNA spikes mix (Fluidigm, no. 100-5582) and 3 μl of nuclease-free 
water (Promega, no. P119C). Cells were lysed by incubation at 65 °C for 90 s 
and cDNA transcription from RNA was performed by reverse transcription 
cycling (25 °C for 5 min, 50 °C for 30 min, 55 °C for 25 min, 60 °C for 5 min and 
70 °C for 10 min) with 1 μl reverse transcription mix solution containing 0.15 μl 
10× SuperScript enzyme mix (Invitrogen, no. 11754-050), 0.12 μl T4 Gene 32 
Protein (New England BioLabs, no. M0300S) and 0.73 μl nuclease-free water. 
The efficiency and specificity of outer and inner primer pairs for target-specific 
cDNA amplification were tested in advance. Primers showing single peaks and 
single bands by melt curve analysis and by separation of qPCR products on a 2.5% 
agarose gel, respectively, were considered specific. Primer efficiency was analysed 
over a range of tenfold cDNA dilutions (1:1 to 1:100) and primers with 100 ± 15 
% efficiency were qualified for further proceedings. Specific target amplification 
was performed with 9 μl reaction mix containing 7.5 μl TaqMan PreAmp Master 
Mix (Applied Biosystems, no. 4391128), 0.075 μl 0.5 M EDTA, pH 8.0 (Invitrogen, 
no. Am9260G), 1.5 μl 10× outer primer mix (500 nM) under the following cycling 
conditions: enzyme activation step at 95 °C for 10 min, 20 cycles of denaturation for 
5 s at 96 °C and 4 min annealing/extension at 60 °C. Amplified cDNA samples were 
then treated with 6 μl Exonuclease I reaction mix containing 0.6 μl reaction buffer, 
1.2 μl Exonuclease I (New England BioLabs, no. M0293S) and 4.2 μl nuclease-free 
water. To increase target specificity, amplified single-cell cDNA samples were 
analysed with gene-specific inner primer pairs and SsoFast EvaGreen Supermix 
with Low ROX (Bio-Rad Laboratories, no. 172-5210) using the 96.96 Dynamic 
Array on the BioMark System (Fluidigm). BioMark Real-Time PCR Analysis 
software (Fluidigm) was used to calculate Ct values.
Computational analyses of single-cell data. A detailed description of the 
computational analyses of single-cell data is provided in the Supplementary 
information.
Statistical analyses. Data collection was performed using Microsoft office 
Excel 2016–2018 and statistical analysis was performed using GraphPad Prism 
6 Software (GraphPad Software). All data are shown as mean ± s.e.m. unless 
otherwise specified. In box-and-whiskers plots, data are represented as minimum 
and maximum with centre lines indicating the median. All samples represent 
biological replicates. For statistical significance testing of two independent groups, 
an unpaired two-tailed Student’s t-test was used. For statistical comparison of 
longitudinal data (body weight curves, GTT and IST), two-way analysis of variance 
corrected by Sidak’s multiple comparison test was used. P values of < 0.05 % were 
considered statistically significant. For metabolic studies (GTT and IST), sample 
size was statistically determined; otherwise sample size estimates were not used. 
Studies were not blinded and investigators were not blinded during analysis.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
All data generated or analysed during this study are included in this article and 
its supplementary files. Microarray data have been submitted to NCBI/GEO 
(GSE148227). scRNA-seq data have been submitted to NCBI/GEO (GSE147319). 
Source data are provided with this paper.
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Extended Data Fig. 1 | See next page for caption.
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Extended Data Fig. 1 | HFHSD remodels the intestinal mucosa and leads to obesity and prediabetes. a, Weekly assessment of body weight. n = 8 mice 
per group. Data are shown as mean ± s.e.m. of biologically independent samples. Statistical significance was determined by two-way ANOVA with 
Sidak’s multiple comparison test. b–d, Analysis of fat (b) and lean mass (c) by nuclear magnetic resonance (NMR) and fat mass ratio (d). n = 3 mice per 
group. Data are shown as mean ± s.e.m.. Statistical significance was determined by two-tailed Student’s t-test. e, f, Assessment of small intestinal length 
(e, n = 10 mice per group) and weight (f, n = 8 mice versus 10 mice per group). Data are shown as mean ± s.e.m. of biologically independent samples. 
Statistical significance was determined by two-tailed Student’s t-test. g–m, Representative LSM images of duodenal sections depicting crypt-villus units 
(g) or crypt regions (k). Assessment of crypt and villus morphology in duodenal and ileal sections. Duodenum: h, j, l, m. Ileum: i, n = 8 mice versus 7 
mice (h), n = 3 mice (i, j), n = 4 mice (l) and n = 8 mice (m) per group. Data are shown as mean ± s.e.m. of biologically independent samples. Statistical 
significance was determined by two-tailed Student’s t-test. Scale bars, 75 µm (g), 25 µm (k). n–p, Cell number (n) and size (o) quantification in the crypts 
(n = 4 mice per group) and cell size quantification in the villi (p, n = 3 mice per group). Data are mean ± s.e.m. of biologically independent samples.  
q, Histological assessment of duodenal tissue sections by haematoxylin and eosin staining. Black square depicts an enlarged villus section. Black 
arrowheads indicate fat inclusions. Scale bar, 100 µm. n = 3 biologically independent CD and HFHSD samples. r, s, Assessment of glucose tolerance 
(r, n = 8 per group) by oral glucose tolerance test (oGTT) and insulin secretion (s, n = 4 mice versus 5 mice per group) by insulin secretion test (IST). 
Data are shown as mean ± s.e.m. of biologically independent samples. Statistical significance was determined by two-way ANOVA with Sidak’s multiple 
comparison test. t, u, Estimation of insulin resistance ((HOMA-IR) and β-cell function (HOMA-β). n = 6 mice per group. Data are shown as mean ± s.e.m. 
of biologically independent samples. Statistical significance was determined by two-tailed Student’s t-test.
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Extended Data Fig. 2 | See next page for caption.
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Extended Data Fig. 2 | Characterization of small intestinal epithelial cell types and lineage relations in CD- and HFHSD-conditions by scrNA-seq. 
a, Representative flow cytometry plot for FVF-based enrichment of SI crypt cells for scRNA-seq. Gating strategy distinguishes FVF-positive cells from 
random live whole crypt cells (FVF all). b, Quality metrics for the scRNA-seq data. c, Levels of cell scores calculated based on the expression of a set of 
known marker genes specific for each cell type and used for cluster annotation. Violin plots show distribution of score levels assigned to the respective 
cell type in CD- and HFHSD-derived samples. d, UMAP plots of crypt cells colored by cell densities of individual CD and HFHSD mice. e, Mean expression 
levels of selected genes known to regulate lineage decisions in intestinal crypt cells of CD and HFHSD mice. *indicates a significant change in HFHSD mice 
(limma, FDR < 0.01, logFC>0.1). f, Lineage relations in CD- and HFHSD-derived SI crypt cells inferred based on a measure for cluster connectivity using 
PAGA. Edges are weighted by significance, node positions are cluster centres in UMAP space. g, Pearson correlation of mean expression profiles of high 
variance genes broken down by cell type and diet. Rows and columns are ordered using hierarchical clustering. h, Frequency shifts of each cluster from 
HFHSD-derived samples compared to CD-derived samples estimated using a Dirichlet-Multinomial model. Expected mean and the 95% highest posterior 
density interval (HPD-region) of the frequency shift for each cell type is shown. A credible shift is assumed if the HPD-region does not include 0. n = 3 CD 
mice. n = 3 HFHSD mice.
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Extended Data Fig. 3 | Proximal- and distal-type enterocytes exert different functions. a, Violin plots showing expression distribution of regional markers 
Onecut2 (proximal) and Bex1 (distal) used to classify proximal and distal cells17 (see Methods). b, Genes and their associated function characteristic for 
enterocytes with proximal or distal identity, respectively. Heatmap shows estimated fold change in proximal versus distal cells from CD-derived samples.
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Extended Data Fig. 4 | Analysis of Foxa2 lineage positive cells and frequency of mature intestinal cell types in FVF mice in CD and HFHSD conditions. 
a, Representative LSM images of tamoxifen-induced recombination in duodenal crypts of CD- and HFHSD-fed Foxa2nEGFP-CreERT2/+; Gt(Rosa26)mTmG/+ mice 
after 48 h. Yellow arrows indicate recombined mG+ slender crypt base cells (CBC) at positions typical for ISCs, adjacent to pyramid-shaped Paneth cells. 
Scale bar, 25 µm. n = 3 biologically independent CD and HFHSD samples. b, Frequencies of coherent Foxa2-lineage ribbons of different sizes in the villi of 
CD- and HFHSD-fed Foxa2nEGFP-CreERT2/+; Gt(Rosa26)mTmG/+ mice at 70 h after tamoxifen induction. n = 3 mice per group. Data are mean ± s.e.m. of biologically 
independent samples. Statistical significance was determined by two-tailed Student’s t-test. c, Percentage of villin+ enterocytes, Muc2+ goblet cells and 
ChgA+ EECs within Foxa2 lineage ribbons. n = 3 mice per group. Data are mean ± s.e.m. of biologically independent samples. Statistical significance was 
determined by two-tailed Student’s t-test. d, e, Quantification of ChgA+ EECs (d, n = 3 mice per group) and Muc2+ goblet cells (e, n = 4 mice per group) in 
ileal tissue sections of CD- and HFHSD-fed FVF mice. Data are shown as mean ± s.e.m. of biologically independent samples. Statistical significance was 
determined by two-tailed Student’s t-test. f, g, Representative LSM images (f) and quantification (g) of Paneth cells (Lyz1+) in the duodenum. Scale bar, 
25 µm, n = 8 mice per group. Data are mean ± s.e.m. of biologically independent samples.
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Extended Data Fig. 5 | regional identity of villi enterocytes is changed upon HFHSD. a, Overview of the experimental setup for scRNA-seq of villi cells. 
b, UMAP plot of 4205 profiled single SI villi cells. Colors highlight clustering into major intestinal cell types based on expression of previously published 
marker genes17. c, UMAP plot of enterocyte progenitors (EP) and enterocytes computed using a set of 44 transcription factors previously described to be 
differential between proximal and distal gut regions17. Colors highlight diet. d, UMAP plot of EP and enterocytes computed using a set of 44 transcription 
factors previously described to be differential between proximal and distal gut regions17. Colors highlight regional annotation. e, Violin plots showing cell 
scores of the proximal and distal transcription factors used in c)17 in CD and HFHSD-derived EPs and enterocytes. f, Proportions of enterocytes and EPs 
annotated as proximal- or distal-type enterocytes based on regional transcription factor scores in c. g, Heatmap showing the log2- fold change of the 
expression of selected functional proximal genes in HFHSD vs CD distal and proximal enterocyte cluster. *indicates a significant change. The p-values are 
provided in Supplementary table 1.
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Extended Data Fig. 6 | See next page for caption.
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Extended Data Fig. 6 | enterocyte zonation is altered upon HFHSD. a, Activation of zonation scores along a pseudospatial ordering of EP and enterocytes 
from SI villi, which reflects the axis from villus bottom to tip. Cell scores for each zone were computed on reported markers18 and approximated by 
polynominal regression fits along the pseudospatial axis. Crossing points of the fitted lines define the partitioning into the five zones. b, Dot plots 
showing the expression of selected markers of enterocyte function in distal and proximal enterocytes. Cells are partitioned into zones along the inferred 
pseudospatial axis from villus bottom (zone 1) to tip (zone 5). c–e, Representative LSM images (c) and quantification of Fabp1 mean fluorescence intensity 
in ileal villi (d) and determination of the length of the Fabp1 positive zone (e). Scale bar, 50 µm, n = 3 CD mice and n = 4 HFHSD mice. Data are shown as 
mean ± s.d. of biologically independent samples. Statistical significance was determined by two-tailed Student’s t-test. f–h, Representative LSM images (f) 
and quantification of Apoa4 mean fluorescence intensity in ileal villi (g) and determination of the length of the Apoa4 positive zone (h). Scale bar, 50 µm, 
n = 3 CD mice and n = 4 HFHSD mice. Data are shown as mean ± s.d. of biologically independent samples. Statistical significance was determined by two-
tailed Student’s t-test. i–k, Representative LSM images (i) and quantification of Apoa4 mean fluorescence intensity in duodenal villi (j) and determination 
of the length of the Apoa4 positive zone (k). Scale bar, 50 µm, n = 5 mice per group. Data are shown as mean ± s.e.m. of biologically independent samples. 
Statistical significance was determined by two-tailed Student’s t-test.
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Extended Data Fig. 7 | See next page for caption.
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Extended Data Fig. 7 | HFHSD changes transcription in eeC subsets and gut plasma hormone levels. a, Violin plots showing the distribution of expression 
of selected genes in EEC clusters. b, PAGA plot showing lineage relationships for the endocrine lineage in CD-derived samples. c, Mean expression levels 
per cluster of genes associated with BMP signaling. d, Mean expression levels per cluster of subset-specific genes in EEC clusters. e, Frequency shifts of 
each cluster from HFHSD-derived samples compared to CD-derived samples estimated using a Dirichlet-Multinomial model. Expected mean and the 
95% highest posterior density interval (HPD-region) of the frequency shift for each cell type is shown. n = 3 mice per group. f–i, Abundance of label-
retaining cells (LRCs). f, Schematic depicting the experimental strategy of the 5-bromo-2-deoxyuridine (BrdU) pulse-chase experiment to determine the 
LRC frequency. g, Representative LSM images of duodenal sections after 14 days of BrdU labelling. BrdU-labelled cells are stained in red. Scale bar, 50 µm. 
n = 3 biologically independent CD and HFHSD mice. h, Representative LSM images of duodenal crypts after a chase period of 21 days. Yellow arrowhead 
highlights a BrdU+/Lyz1− LRC. Blue arrowheads indicate BrdU+/Lyz1+ cells. Scale bar, 25 µm. i, Proportion of Lyz1− and Lyz1+ BrdU-labelled cells of total 
BrdU+ cells in duodenal crypts. n = 4 mice versus 5 mice per group. Data are presented as mean ± s.e.m. of biologically independent samples. Statistical 
significance was determined by two-tailed Student’s t-test. j, Mean hormone expression levels in EECs. Mean was calculated only from cells with high 
expression levels (log (count > 3). k–m, Differential gene expression in selected EEC clusters tested using limma. For each gene, the estimated logFC  
and its associated FDR is plotted. Red lines indicate thresholds used for significance level and gene expression change. Regulated genes are highlighted  
in black, of which annotated genes are the top 10 genes ranked by FDR. n, Experimental scheme for the assessment of selected hormone plasma levels. 
o–q, Plasma levels of serotonin (n = 4 mice per group) (o), ghrelin (n = 5 mice /4 mice per group) (p) and Glp-1 (n = 5 mice /4 mice per group) (q).  
Data represent mean ± s.e.m. of biologically independent mice. Statistical significance was determined by two-tailed Student’s t-test.
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Extended Data Fig. 8 | See next page for caption.
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Extended Data Fig. 8 | HFHSD increases turnover of SI crypt cells. a, Left: Cell score levels for cell-cycle phases S and G2/M calculated based on 
the expression of a set of genes related to cell-cycle are visualized in a UMAP plot. Right: Cells assigned to the corresponding cell-cycle phase are 
highlighted in red. b, Proportions of cycling cells assigned to S and G2/M cell-cycle phases in CD and HFHSD-derived in indicated clusters. Table indicates 
percentages. Data are shown as mean ± s.e.m., n = 3 mice per group. c, Assessment of body weight over the course of 14 weeks of CD- and HFHSD-fed 
Lgr5-ki mice. n = 4 per group. Data are shown as mean ± s.e.m. of biologically independent samples. Statistical significance was determined by two-tailed 
Student’s t-test. d, Representative FACS plots showing gating strategy to determine the proportion of Lgr5-EGFPhi cells (ISCs) in CD and HFHSD fed 
Lgr5-ki mice. e, f, Representative LSM images (e) and quantification (f) of Ki67+ (green) proliferative regions. Scale bar, 75 µm, n = 4 mice per group. Data 
are mean ± s.e.m. of biologically independent samples. Statistical significance was determined by two-tailed Student’s t-test. g–i, Representative LSM 
images of BrdU-labelled cells (BrdU+ nuclei, red) along the crypt-villus axis 24 h after BrdU administration in duodenal sections from CD- and HFHSD-
fed FVF mice (g). Quantification of cell migration length by measuring the distance from the crypt base to the highest labelled cell in the villus (h). Net 
BrdU migration (i), calculated as the average distance of BrdU-labelled migration front minus the Ki67+ zone to correct for increased cell proliferation on 
HFHSD. Scale bar, 25 µm. n = 4 mice per group. Data are mean ± s.e.m. of biologically independent samples. Statistical significance was determined by 
two-tailed Student’s t-test.
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Extended Data Fig. 9 | HFHSD stimulates the Insr/Igf1r/Akt pathway and fatty acid synthesis and Ppar signaling. a, b, Representative immunoblots of 
phosphorylated (p)Igf1r/Insr (Tyr1158/Tyr1162/Tyr1163) and total Igf1r, Insrβ, pAkt (Ser473) and total Akt (a) and quantification of the protein levels (b). 
Protein expression was analysed in whole-cell lysates from SI crypts of CD- and HFHSD-fed FVF animals. For quantification, signal intensities of all protein 
bands were normalised to α-tubulin; phosphorylated proteins were additionally normalised to the corresponding non-phosphorylated protein. n = 3 mice 
per group for pIgf1r/pInsr, n = 7 mice per group for Igf1r, n = 9 mice per group for (p)Akt and total Akt. Data are presented as box-and-whisker plots. The 
lower and upper boundaries of the boxes represent the 25th and 75th percentiles, respectively. The center lines indicate the medians, the crosses denote 
the mean values, and whiskers represent the maximum and minimum values. Statistical significance was determined by two-tailed Student’s t-test. Circles 
represent biological independent samples. c, Mean expression levels per cluster of genes involved in PI3K/Akt signaling in CD and HFHSD. * indicates 
a significant change in HFHSD mice (limma, FDR < 0.01, logFC>0.1)). The p-values are provided in Supplementary table 1. d, Predicted activation or 
inhibition of upstream regulators in bulk transcriptomics. Significantly regulated genes from each population (each HFHSD versus CD) were analysed by 
Ingenuity Pathway Software to predict the activation (yellow; z-score >2) or inhibition (blue; z-score < −2) of upstream regulators. Shown are all genes 
with three z-scores available and from which at least two were significant (z-score > ׀ 2׀).
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Extended Data Fig. 10 | Confirmation of expression differences in metabolic genes in FVF-positive cells from CD- and HFHSD-fed mice by targeted 
single-cell qPCr. a, b, UMAP plot of 465 profiled FVF positive crypt cells from 3 CD and 3 HFHSD-fed mice coloured by cell type (a). Cluster annotation 
was based on lineage marker gene expression depicted in the heatmap (b). c, Violin plots showing expression of selected metabolic genes related to fatty 
acid synthesis, Ppar signaling and glycolysis in indicated single-cell clusters split by diet.
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Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) 
AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection 1. Microsoft office excel 2016-2018 
2. qPCR was carried out using the Viia7 Real Time PCR System (Thermo Fisher Scientific). 
3. Microarray data was obtained using Agilent 2100 Bioanalyzer and Affymetrix Mouse Gene 1.0 ST arrays. 
4. MALDI-MSI measurements were obtained with a Bruker Solarix 7T FT-ICR-MS (Bruker Daltonics, Bremen, Germany) and after matrix 
removal scanned with a MIRAX DESK digital slide-scanning system (Carl Zeiss MicroImaging, Göttingen, Germany). 
5. Western blot analysis was carried out using UVP Chem Studio SA (Analytik Jena AG, Biometra GmbH Jena Germany). 
6. Tissue histology images were obtained with a Zeiss AXIO Scope A1 microscope (Carl Zeiss AG, Germany). 
7. Fluorescent histological images were obtained with a Leica SP5 Confocal microscope (Leica Microsystems, Germany) using the LAS AF 
software v2.6.0-7266. 
8. single-cell qRT-PCR were run on 96 × 96 Dynamic Array on the BioMark System (Fluidigm). Ct values for each gene in each cell was 
calculated using BioMark Real-Time PCR Analysis software v3 (Fluidigm). 
9. single-cell libraries were sequenced on the HiSeq4000 (Illumina) with 150 bp paired-end sequencing of read 2. 
10. BD FACS ARIA III and BD FACSDiva software v6.1.3  
11. EchoMRI, Houston, TX, USA for body composition analysis 
Data analysis 1. Prism 6 software  (Graphpad) http://www.graphpad.com/scientific-software/ N/A prism/. 
2. Microarray was processed with Expression Console (v.1.3.0.187, Affymetrix),  
3. Spectra processing of MALDI-MSI data was done with FlexImaging v. 4.2. 
4. MATLAB R2014b (v.7.10.0, Mathworks, Inc., Natick, MA) was used as MALDI spectral pre-processing tool for the subsequent data 
bioinformatics analysis, LIMPIC algorithm was used for peak picking 
5. Metabolite annotation was performed with databases (METLIN, http://metlin.scripps.edu/; Human Metabolome Database, http://
www.hmdb.ca/; MassTRIX, http://masstrix3.helmholtz-muenchen.de/masstrix3/; METASPACE,http://annotate. metaspace 2020.eu/).  
6. Heatmap-based clustering and enrichment analysis of metabolic pathways were performed with MetaboAnalyst 3.0 (http://
www.metaboanalyst.ca). 
7. Western blots protein bands were quantified with the ImageJ software v1.51.   
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8. Histological images were analyzed using the LAS AF software program v2.6.0-7266.. 
9. scRNA-seq data were analyzed using python 3.5.4, 3.6.12 and 3.7.5. The raw reads were processed using the CellRanger analysis 
pipeline (v2.0.0) provided by 10X Genomics. Subsequent analyzes were carried out using custom scripts, Scanpy (https://github.com/
theislab/scanpy, v1.0.4+92.g9a754bb and 1.4.4post for velocity estimation and scRNA-seq of villi cells), scVelo (0.1.26.dev7+g5e6d395, 
https://github.com/theislab/scvelo with scanpy v1.3.4), velocyto (v0.17.7, http://velocyto.org), limma (http://bioinf.wehi.edu.au/limma/, 
v3.28.10) via an rpy2 interface (v2.9.1) and gseapy  (v0.9.3) implementation of EnrichR (2018/2019). 
10. QIAGEN’s Ingenuity Pathway Analysis (IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity). 
11. CARMAweb  
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. 
We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
All data generated or analysed during this study are included in this published article and its Supplementary Information files. Source data are provided with this 
paper.  
Microarray data have been submitted to NCBI/GEO (GSE148227). 
scRNAseq data have been submitted to NCBI/GEO (GSE147319). 
Code and custom scripts for scRNAseq analysis have been deposited on https://github.com/theislab/2021_Aliluev_Tritschler_gut_HFD. 
Databases: http://metlin.scripps.edu/; Human Metabolome Database, http://www.hmdb.ca/; MassTRIX, http://masstrix3.helmholtz-muenchen.de/masstrix3/; 
METASPACE,http://annotate. metaspace 2020.eu/ 
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Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size Sample size was calculated based on α-error=0.05, power=0.8, and effect size=1.58. We obtained a sample size of n=>8/condition group for 
physiological measurements during the high-fat high sugar diet feeding based on published data.  
 
For single-cell RNA-seq a minimum expected requirement of ~3000 cells per experiment was used and by far exceeded in all cases for 
confident identification of rare cell subpopulations (~0.05% of cells). No statistical test or power analyzes were used to pre-determine sample 
size. 
Otherwise, we chose the sample size of individual experiments based on past experience on detecting differences with a given method and 
relevant literature (PMID: 26935695, PMID: 22722868, PMID: 29727683).
Data exclusions For the single-cell RNAseq data cells were filtered using previously described standards for quality control. For each experiment the count 
matrix was filtered as follows: for scRNA-seq samples of crypt cells genes with expression in less than 20 cells were removed and cells with a 
fraction of UMI counts from mitochondrially encoded genes of 10% or more were excluded, for scRNA-seq samples of villi cells genes with 
expression in less than 5 cells were removed and cells with a fraction of UMI counts from mitochondrially encoded genes of 25% or more 
were excluded. These criteria were based on the cell quality within this study. Otherwise, no data were excluded. Some mice that were on a 
HFHSD did not gain weight (=non-responder) and were excluded from the analysis.
Replication Experiments were performed at least in triplicates most with three or more biological replicates unless otherwise indicated. All attempts of 
replication were successful. Further details about the replication of data are stated in the figure legends. 
Randomization For dietary interventions mice were randomized into test groups based on body weight distribution. For microscopy, the fields of images were 
randomly selected.  For FACS experiments, at least 50,000 events were randomly sampled by the FACS machine. Most other results were 
derived from computation therefore randomization was not required.
Blinding The investigators were not blinded to group allocation during in vivo experiments as CD and HFHSD mice were clearly distinguishable by eye. 
Investigators were not blinded during data collection or analysis as most experiments/analyses were performed by automatic devices such as 
the FACS or qPCR cycler. For cell-based assays such as Western blot or qPCR blinding was not possible because the experiments were 
performed by a single researcher. 
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Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
Materials & experimental systems













Antibodies used primary antibodies: 
chicken anti-GFP (1:600, Aves Labs, USA, GFP-1020);  
goat anti-ChgA (1:200, Santa Cruz, sc-1488);  
rabbit anti-Lyz1 (1:1000, DAKO, M0776);  
rabbit anti-Muc2 (1:1000, Santa Cruz, sc-7314);  
rat anti-BrdU (1:200, Abcam, ab6326);  
rabbit anti-5-HT (1:1000, Neuromics, RA20080);  
anti-rabbit Ngn3 (1:100, a gift from Helena Edlund lab);  
goat anti-villin (1:200, Santa Cruz, sc-7672);  
goat anti-ghrelin (1:200, Santa Cruz, sc-10368);  
rabbit anti-Ki67 (1:200, Abcam, ab15580);  
rabbit anti-E-cadherin (extracellular domain) (1:1000, a gift from Dietmar Vestweber) 
mouse anti-Srebp1 (1:1000, Novus Biologicals, NB600-582SS);  
rabbit anti-Acc (1:1000, Cell Signaling Technology, 3676);  
rabbit anti-Pparγ (1:1000, Cell Signaling Technology, 2435);  
goat anti-lamin (1:1000, Santa Cruz, sc-6217);  
mouse anti-α-tubulin (1:1000, Sigma-Aldrich ,T6199);  
rabbit anti-Fasn 1:1000, Cell Signaling Technology, 3180);  
rabbit anti-Scd1 (1:1000, Cell Signaling Technology, 2794);  
mouse anti-β-Catenin (1:1000, BD, 610154); 
rabbit anti-Gsk3β (1:5000, Cell Signaling Technology, 12456); 
rabbit anti-phospho Gsk3β (1:5000, Cell Signaling Technology, 5558) 
 
Secondary antibodies: 
donkey anti-chicken Alexa Fluor 488 (1:800, Dianova, 703-225-155);  
donkey anti-mouse Cy5 (1:800, Dianova, 715-175-151);  
donkey anti-goat Alexa Fluor 555 (1:800, Invitrogen, A21432);  
donkey anti-rabbit Alexa Fluor 555 (1:800, Invitrogen, A31572);  
donkey anti-rabbit Alexa Fluor 649 (1:800, Dianova, 711-605-152); 
goat anti-mouse HRP (1:15000, Dianova, 115-036-062);  
goat anti-rabbit HRP (1:15000, Dianova, 111-036-045); 
rabbit anti-goat HRP (1:15000, Dianova, 305-035-045) 
Validation primary antibodies: antibodies were validated by the company 
chicken anti-GFP (1:600, Aves Labs, USA, GFP-1020); https://www.aveslabs.com/products/green-fluorescent-protein-gfp-
antibody 
goat anti-ChgA (1:200, Santa Cruz, sc-1488); https://www.scbt.com/de/p/chr-a-antibody-c-20 
rabbit anti-Lyz1 (1:1000, DAKO, M0776); https://www.labome.com/product/Dako/A0099.html 
rabbit anti-Muc2 (1:1000, Santa Cruz, sc-7314); https://www.scbt.com/p/mucin-2-antibody-ccp58 
rat anti-BrdU (1:200, Abcam, ab6326); https://www.abcam.com/brdu-antibody-bu175-icr1-proliferation-marker-ab6326.html 
rabbit anti-5-HT (1:1000, Neuromics, RA20080); https://www.neuromics.com/RA20080 
anti-rabbit Ngn3 (1:100, a gift from Helena Edlund lab); as a control we used a secondary antibody only control, https://
pubmed.ncbi.nlm.nih.gov/31160421/ 
goat anti-villin (1:200, Santa Cruz, sc-7672); https://www.scbt.com/de/p/villin-antibody-c-19 
goat anti-ghrelin (1:200, Santa Cruz, sc-10368); https://www.scbt.com/p/ghrelin-antibody-c-18 
rabbit anti-Ki67 (1:200, Abcam, ab15580); https://www.abcam.com/ki67-antibody-ab15580.html 
rabbit anti-E-cadherin (extracellular domain) (1:1000, a gift from Dietmar Vestweber) 
mouse anti-Srebp1 (1:1000, Novus Biologicals, NB600-582SS); https://www.novusbio.com/products/srebp1-
antibody-2a4_nb600-582 
rabbit anti-Acc (1:1000, Cell Signaling Technology, 3676); https://www.cellsignal.de/products/primary-antibodies/acetyl-coa-
carboxylase-c83b10-rabbit-mab/3676 
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rabbit anti-Pparγ (1:1000, Cell Signaling Technology, 2435); https://www.cellsignal.de/products/primary-antibodies/pparg-
c26h12-rabbit-mab/2435 
goat anti-lamin (Santa Cruz, sc-6217); https://www.scbt.com/de/p/lamin-b-antibody-m-20 
mouse anti-α-tubulin (Sigma-Aldrich ,T6199); https://www.sigmaaldrich.com/catalog/product/sigma/t6199?lang=de&region=DE 
rabbit anti-Fasn 1:1000, Cell Signaling Technology, 3180); https://www.cellsignal.de/products/primary-antibodies/fatty-acid-
synthase-c20g5-rabbit-mab/3180 
rabbit anti-Scd1 (1:1000, Cell Signaling Technology, 2794); https://www.cellsignal.de/products/primary-antibodies/scd1-c12h5-
rabbit-mab/2794  
mouse anti-β-Catenin (BD, 610154); https://www.bdbiosciences.com/us/applications/research/stem-cell-research/cancer-
research/human/purified-mouse-anti--catenin-14beta-catenin/p/610154 
rabbit anti-Gsk3β (1:5000, Cell Signaling Technology, 12456); https://www.cellsignal.de/products/primary-antibodies/gsk-3b-
d5c5z-xp-rabbit-mab/12456 




donkey anti-chicken Alexa Fluor 488 (Dianova, 703-225-155); https://www.dianova.com/en/shop/703-175-155-donkey-igg-anti-
chicken-igy-hl-cy5-minx-bogogphshohumsrbrtsh/ 
donkey anti-mouse Cy5 (Dianova, 715-175-151); https://www.dianova.com/en/shop/715-175-151-donkey-igg-anti-mouse-igg-hl-
cy5-minx-bockgogphshohurbrtsh/ 
donkey anti-goat Alexa Fluor 555 (Invitrogen, A21432); https://www.thermofisher.com/antibody/product/Donkey-anti-Goat-IgG-
H-L-Cross-Adsorbed-Secondary-Antibody-Polyclonal/A-21432 
donkey anti-rabbit Alexa Fluor 555 (Invitrogen, A31572); https://www.thermofisher.com/antibody/product/Donkey-anti-Rabbit-
IgG-H-L-Highly-Cross-Adsorbed-Secondary-Antibody-Polyclonal/A-31572 
donkey anti-rabbit Alexa Fluor 649 (Dianova, 711-605-152); https://www.dianova.com/shop/711-605-152-esel-igg-anti-
kaninchen-igg-hl-alexa-fluor-647-minx-bockgogphshohumsrtsh/ 
goat anti-mouse HRP (1:15000, Dianova, 115-036-062); https://www.dianova.com/shop/115-036-062-ziege-fab2-anti-maus-igg-
hl-hrpo-minx-huboho/ 
goat anti-rabbit HRP (1:15000, Dianova, 111-036-045); https://www.dianova.com/shop/111-036-045-ziege-fab2-anti-kaninchen-
igg-hl-hrpo-minx-hu/ 
rabbit anti-goat HRP (1:15000, Dianova, 305-035-045); https://www.dianova.com/shop/305-035-045-kaninchen-igg-anti-ziege-
igg-hl-hrpo-minx-hu/ 
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals Homozygous Foxa2-Venus fusion (FVF) mice were generated as previously described and backcrossed to C57BL/6 background. 
Foxa2nEGFP-CreERT2 mice (CD1 background) were crossed with Gt(ROSA)26mTmG mice (mixed 129/SvJ, C57BL/6J background) 
to obtain heterozygous Foxa2nEGFP-CreERT2/+; Gt(ROSA)26 mTmG/+ animals and bred in our own facilities. Other mouse lines: 
Lgr5-EGFP-IRES-creERT232 (Lgr5-ki, C57BL/6J background), wild-type C57BL/6N (bred in our own facilities).  
Mice were housed in groups of two to four animals and maintained at 23 ± 1 ⁰C on a 12-hour dark/light cycle with ad libitum 
access to diet and water unless otherwise indicated. All experiments were performed using male animals 3 to 7 months of age.  
 
All experiments were performed using 3-7-month-old male mice.  
Mice were housed in groups of two to four animals and maintained at 23 ± 1 ⁰C and 45-65 % humidity on a 12-hour dark/light 
cycle with ad libitum access to diet and water unless otherwise indicated. 
Wild animals The study did not involve wild animals
Field-collected samples No field collected samples were used in this study.
Ethics oversight Animal experiments were carried out in compliance with the German Animal Protection Act and with the approved guidelines of 
the Society of Laboratory Animals (GV-SOLAS) and of the Federation of Laboratory Animal Science Associations (FELASA). This 
study was approved by the institutional Animal Welfare Officer (Helmholtz Center Munich) and by the Government of Upper 
Bavaria, Germany.  




The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
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Sample preparation Small intestines were removed and washed with cold PBS. Villi were scraped off with a glass slide. The remaining tissue was cut 
into 2-cm pieces, washed several times with cold PBS and incubated in 2 mM EDTA/PBS for 35 min at 4 °C on a tube roller. 
Subsequently, crypts were harvested by rigorous shaking and filtered through a 70-μm mesh to remove villous contaminations/
fragments. 
Isolated crypts were incubated with TrypLE (Life technologies, #12605) for 5 min on ice and then 5 min at 37 °C and treated with 
10 μg/ml DNase in crypt complete medium (DMEM/F-12 containing 10 % FCS) for 5 min at 37 °C. 
Single cell suspension was achieved by gentle repeated pipetting. Cells were washed twice with FACS buffer (2 % FCS, 2 mM 
EDTA in PBS) and pelleted at 300xg, 5 min, 4 °C. For flow cytometry, cells were collected in 1-2 ml FACS buffer supplemented 
with 10 μM Rock-inhibitor (Sigma-Aldrich, #Y0503) and passed through the 40 μm cell strainer caps of FACS tubes. 
Instrument Single cells were analyzed by FACS-Aria III (BD) with a 100 μm nozzle.
Software Data were analyzed with the FACS DIVA software v6.1.3.
Cell population abundance Abundance of intestinal cell populations (from live cells = 40-60%) are reported in this manuscript and source data (Fig. 4g, F, 
Extended  Data Fig. 9a). When possible purity of post-sort fractions were checked by briefly re-running a small amount of 
sample. Purity was usually 90-95%. 
Gating strategy Single cells were gated according to their FSC-A (front scatter area) and SSC-A (side scatter area). Singlets were gated dependent 
on the FSC-W (front scatter width) and FSC-H (front scatter height) and SSC-W and SSC-H and dead cells were excluded using the 
marker7AAD (eBioscience). To obtain FVF-enriched small intestinal crypt cell samples for single-cell RNA sequencing, 30,000 FVF
+ (FVFlow and FVFhi) cells were sorted followed by sorting 30,000 live crypt cells per sample.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
